<?xml version="1.0" encoding="utf-8"?>
<LCTL_TEXT>
	<DOC id="covid19scenario-56">
		<TEXT>
			<SEG id="covid19scenario-56-0" start_char="0" end_char="233">
				<ORIGINAL_TEXT>On April 24, News Front Georgia, a pro-Kremlin news site popular in the former Soviet states, published a Georgian language article headlined: “Anti-corona medication of an American firm linked to ‘Lugar Lab’ turns out to be useless.”</ORIGINAL_TEXT>
				<TOKEN id="token-0-0" start_char="0" end_char="1">On</TOKEN>
				<TOKEN id="token-0-1" start_char="3" end_char="7">April</TOKEN>
				<TOKEN id="token-0-2" start_char="9" end_char="10">24</TOKEN>
				<TOKEN id="token-0-3" start_char="11" end_char="11">,</TOKEN>
				<TOKEN id="token-0-4" start_char="13" end_char="16">News</TOKEN>
				<TOKEN id="token-0-5" start_char="18" end_char="22">Front</TOKEN>
				<TOKEN id="token-0-6" start_char="24" end_char="30">Georgia</TOKEN>
				<TOKEN id="token-0-7" start_char="31" end_char="31">,</TOKEN>
				<TOKEN id="token-0-8" start_char="33" end_char="33">a</TOKEN>
				<TOKEN id="token-0-9" start_char="35" end_char="37">pro</TOKEN>
				<TOKEN id="token-0-10" start_char="38" end_char="38">-</TOKEN>
				<TOKEN id="token-0-11" start_char="39" end_char="45">Kremlin</TOKEN>
				<TOKEN id="token-0-12" start_char="47" end_char="50">news</TOKEN>
				<TOKEN id="token-0-13" start_char="52" end_char="55">site</TOKEN>
				<TOKEN id="token-0-14" start_char="57" end_char="63">popular</TOKEN>
				<TOKEN id="token-0-15" start_char="65" end_char="66">in</TOKEN>
				<TOKEN id="token-0-16" start_char="68" end_char="70">the</TOKEN>
				<TOKEN id="token-0-17" start_char="72" end_char="77">former</TOKEN>
				<TOKEN id="token-0-18" start_char="79" end_char="84">Soviet</TOKEN>
				<TOKEN id="token-0-19" start_char="86" end_char="91">states</TOKEN>
				<TOKEN id="token-0-20" start_char="92" end_char="92">,</TOKEN>
				<TOKEN id="token-0-21" start_char="94" end_char="102">published</TOKEN>
				<TOKEN id="token-0-22" start_char="104" end_char="104">a</TOKEN>
				<TOKEN id="token-0-23" start_char="106" end_char="113">Georgian</TOKEN>
				<TOKEN id="token-0-24" start_char="115" end_char="122">language</TOKEN>
				<TOKEN id="token-0-25" start_char="124" end_char="130">article</TOKEN>
				<TOKEN id="token-0-26" start_char="132" end_char="140">headlined</TOKEN>
				<TOKEN id="token-0-27" start_char="141" end_char="141">:</TOKEN>
				<TOKEN id="token-0-28" start_char="143" end_char="143">“</TOKEN>
				<TOKEN id="token-0-29" start_char="144" end_char="147">Anti</TOKEN>
				<TOKEN id="token-0-30" start_char="148" end_char="148">-</TOKEN>
				<TOKEN id="token-0-31" start_char="149" end_char="154">corona</TOKEN>
				<TOKEN id="token-0-32" start_char="156" end_char="165">medication</TOKEN>
				<TOKEN id="token-0-33" start_char="167" end_char="168">of</TOKEN>
				<TOKEN id="token-0-34" start_char="170" end_char="171">an</TOKEN>
				<TOKEN id="token-0-35" start_char="173" end_char="180">American</TOKEN>
				<TOKEN id="token-0-36" start_char="182" end_char="185">firm</TOKEN>
				<TOKEN id="token-0-37" start_char="187" end_char="192">linked</TOKEN>
				<TOKEN id="token-0-38" start_char="194" end_char="195">to</TOKEN>
				<TOKEN id="token-0-39" start_char="197" end_char="197">‘</TOKEN>
				<TOKEN id="token-0-40" start_char="198" end_char="202">Lugar</TOKEN>
				<TOKEN id="token-0-41" start_char="204" end_char="206">Lab</TOKEN>
				<TOKEN id="token-0-42" start_char="207" end_char="207">’</TOKEN>
				<TOKEN id="token-0-43" start_char="209" end_char="213">turns</TOKEN>
				<TOKEN id="token-0-44" start_char="215" end_char="217">out</TOKEN>
				<TOKEN id="token-0-45" start_char="219" end_char="220">to</TOKEN>
				<TOKEN id="token-0-46" start_char="222" end_char="223">be</TOKEN>
				<TOKEN id="token-0-47" start_char="225" end_char="231">useless</TOKEN>
				<TOKEN id="token-0-48" start_char="232" end_char="233">.”</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-1" start_char="235" end_char="254">
				<ORIGINAL_TEXT>The report is false.</ORIGINAL_TEXT>
				<TOKEN id="token-1-0" start_char="235" end_char="237">The</TOKEN>
				<TOKEN id="token-1-1" start_char="239" end_char="244">report</TOKEN>
				<TOKEN id="token-1-2" start_char="246" end_char="247">is</TOKEN>
				<TOKEN id="token-1-3" start_char="249" end_char="253">false</TOKEN>
				<TOKEN id="token-1-4" start_char="254" end_char="254">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-2" start_char="256" end_char="407">
				<ORIGINAL_TEXT>News Front claimed the results in the first clinical trial of the U.S.-developed antiviral drug remdesivir showed it to be ineffective against COVID-19.</ORIGINAL_TEXT>
				<TOKEN id="token-2-0" start_char="256" end_char="259">News</TOKEN>
				<TOKEN id="token-2-1" start_char="261" end_char="265">Front</TOKEN>
				<TOKEN id="token-2-2" start_char="267" end_char="273">claimed</TOKEN>
				<TOKEN id="token-2-3" start_char="275" end_char="277">the</TOKEN>
				<TOKEN id="token-2-4" start_char="279" end_char="285">results</TOKEN>
				<TOKEN id="token-2-5" start_char="287" end_char="288">in</TOKEN>
				<TOKEN id="token-2-6" start_char="290" end_char="292">the</TOKEN>
				<TOKEN id="token-2-7" start_char="294" end_char="298">first</TOKEN>
				<TOKEN id="token-2-8" start_char="300" end_char="307">clinical</TOKEN>
				<TOKEN id="token-2-9" start_char="309" end_char="313">trial</TOKEN>
				<TOKEN id="token-2-10" start_char="315" end_char="316">of</TOKEN>
				<TOKEN id="token-2-11" start_char="318" end_char="320">the</TOKEN>
				<TOKEN id="token-2-12" start_char="322" end_char="322">U</TOKEN>
				<TOKEN id="token-2-13" start_char="323" end_char="323">.</TOKEN>
				<TOKEN id="token-2-14" start_char="324" end_char="324">S</TOKEN>
				<TOKEN id="token-2-15" start_char="325" end_char="326">.-</TOKEN>
				<TOKEN id="token-2-16" start_char="327" end_char="335">developed</TOKEN>
				<TOKEN id="token-2-17" start_char="337" end_char="345">antiviral</TOKEN>
				<TOKEN id="token-2-18" start_char="347" end_char="350">drug</TOKEN>
				<TOKEN id="token-2-19" start_char="352" end_char="361">remdesivir</TOKEN>
				<TOKEN id="token-2-20" start_char="363" end_char="368">showed</TOKEN>
				<TOKEN id="token-2-21" start_char="370" end_char="371">it</TOKEN>
				<TOKEN id="token-2-22" start_char="373" end_char="374">to</TOKEN>
				<TOKEN id="token-2-23" start_char="376" end_char="377">be</TOKEN>
				<TOKEN id="token-2-24" start_char="379" end_char="389">ineffective</TOKEN>
				<TOKEN id="token-2-25" start_char="391" end_char="397">against</TOKEN>
				<TOKEN id="token-2-26" start_char="399" end_char="403">COVID</TOKEN>
				<TOKEN id="token-2-27" start_char="404" end_char="404">-</TOKEN>
				<TOKEN id="token-2-28" start_char="405" end_char="406">19</TOKEN>
				<TOKEN id="token-2-29" start_char="407" end_char="407">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-3" start_char="409" end_char="528">
				<ORIGINAL_TEXT>It also linked the medication with the debunked and recycled anti-U.S. conspiracy theory about the Lugar Lab in Georgia.</ORIGINAL_TEXT>
				<TOKEN id="token-3-0" start_char="409" end_char="410">It</TOKEN>
				<TOKEN id="token-3-1" start_char="412" end_char="415">also</TOKEN>
				<TOKEN id="token-3-2" start_char="417" end_char="422">linked</TOKEN>
				<TOKEN id="token-3-3" start_char="424" end_char="426">the</TOKEN>
				<TOKEN id="token-3-4" start_char="428" end_char="437">medication</TOKEN>
				<TOKEN id="token-3-5" start_char="439" end_char="442">with</TOKEN>
				<TOKEN id="token-3-6" start_char="444" end_char="446">the</TOKEN>
				<TOKEN id="token-3-7" start_char="448" end_char="455">debunked</TOKEN>
				<TOKEN id="token-3-8" start_char="457" end_char="459">and</TOKEN>
				<TOKEN id="token-3-9" start_char="461" end_char="468">recycled</TOKEN>
				<TOKEN id="token-3-10" start_char="470" end_char="473">anti</TOKEN>
				<TOKEN id="token-3-11" start_char="474" end_char="474">-</TOKEN>
				<TOKEN id="token-3-12" start_char="475" end_char="475">U</TOKEN>
				<TOKEN id="token-3-13" start_char="476" end_char="476">.</TOKEN>
				<TOKEN id="token-3-14" start_char="477" end_char="477">S</TOKEN>
				<TOKEN id="token-3-15" start_char="478" end_char="478">.</TOKEN>
				<TOKEN id="token-3-16" start_char="480" end_char="489">conspiracy</TOKEN>
				<TOKEN id="token-3-17" start_char="491" end_char="496">theory</TOKEN>
				<TOKEN id="token-3-18" start_char="498" end_char="502">about</TOKEN>
				<TOKEN id="token-3-19" start_char="504" end_char="506">the</TOKEN>
				<TOKEN id="token-3-20" start_char="508" end_char="512">Lugar</TOKEN>
				<TOKEN id="token-3-21" start_char="514" end_char="516">Lab</TOKEN>
				<TOKEN id="token-3-22" start_char="518" end_char="519">in</TOKEN>
				<TOKEN id="token-3-23" start_char="521" end_char="527">Georgia</TOKEN>
				<TOKEN id="token-3-24" start_char="528" end_char="528">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-4" start_char="530" end_char="642">
				<ORIGINAL_TEXT>Remdesivir is an experimental antiviral medication created by the U.S. biopharmaceutical company Gilead Sciences.</ORIGINAL_TEXT>
				<TOKEN id="token-4-0" start_char="530" end_char="539">Remdesivir</TOKEN>
				<TOKEN id="token-4-1" start_char="541" end_char="542">is</TOKEN>
				<TOKEN id="token-4-2" start_char="544" end_char="545">an</TOKEN>
				<TOKEN id="token-4-3" start_char="547" end_char="558">experimental</TOKEN>
				<TOKEN id="token-4-4" start_char="560" end_char="568">antiviral</TOKEN>
				<TOKEN id="token-4-5" start_char="570" end_char="579">medication</TOKEN>
				<TOKEN id="token-4-6" start_char="581" end_char="587">created</TOKEN>
				<TOKEN id="token-4-7" start_char="589" end_char="590">by</TOKEN>
				<TOKEN id="token-4-8" start_char="592" end_char="594">the</TOKEN>
				<TOKEN id="token-4-9" start_char="596" end_char="596">U</TOKEN>
				<TOKEN id="token-4-10" start_char="597" end_char="597">.</TOKEN>
				<TOKEN id="token-4-11" start_char="598" end_char="598">S</TOKEN>
				<TOKEN id="token-4-12" start_char="599" end_char="599">.</TOKEN>
				<TOKEN id="token-4-13" start_char="601" end_char="617">biopharmaceutical</TOKEN>
				<TOKEN id="token-4-14" start_char="619" end_char="625">company</TOKEN>
				<TOKEN id="token-4-15" start_char="627" end_char="632">Gilead</TOKEN>
				<TOKEN id="token-4-16" start_char="634" end_char="641">Sciences</TOKEN>
				<TOKEN id="token-4-17" start_char="642" end_char="642">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-5" start_char="644" end_char="755">
				<ORIGINAL_TEXT>It was developed as an anti-Ebola drug which, despite multiple trials, has never been approved for use anywhere.</ORIGINAL_TEXT>
				<TOKEN id="token-5-0" start_char="644" end_char="645">It</TOKEN>
				<TOKEN id="token-5-1" start_char="647" end_char="649">was</TOKEN>
				<TOKEN id="token-5-2" start_char="651" end_char="659">developed</TOKEN>
				<TOKEN id="token-5-3" start_char="661" end_char="662">as</TOKEN>
				<TOKEN id="token-5-4" start_char="664" end_char="665">an</TOKEN>
				<TOKEN id="token-5-5" start_char="667" end_char="670">anti</TOKEN>
				<TOKEN id="token-5-6" start_char="671" end_char="671">-</TOKEN>
				<TOKEN id="token-5-7" start_char="672" end_char="676">Ebola</TOKEN>
				<TOKEN id="token-5-8" start_char="678" end_char="681">drug</TOKEN>
				<TOKEN id="token-5-9" start_char="683" end_char="687">which</TOKEN>
				<TOKEN id="token-5-10" start_char="688" end_char="688">,</TOKEN>
				<TOKEN id="token-5-11" start_char="690" end_char="696">despite</TOKEN>
				<TOKEN id="token-5-12" start_char="698" end_char="705">multiple</TOKEN>
				<TOKEN id="token-5-13" start_char="707" end_char="712">trials</TOKEN>
				<TOKEN id="token-5-14" start_char="713" end_char="713">,</TOKEN>
				<TOKEN id="token-5-15" start_char="715" end_char="717">has</TOKEN>
				<TOKEN id="token-5-16" start_char="719" end_char="723">never</TOKEN>
				<TOKEN id="token-5-17" start_char="725" end_char="728">been</TOKEN>
				<TOKEN id="token-5-18" start_char="730" end_char="737">approved</TOKEN>
				<TOKEN id="token-5-19" start_char="739" end_char="741">for</TOKEN>
				<TOKEN id="token-5-20" start_char="743" end_char="745">use</TOKEN>
				<TOKEN id="token-5-21" start_char="747" end_char="754">anywhere</TOKEN>
				<TOKEN id="token-5-22" start_char="755" end_char="755">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-6" start_char="757" end_char="827">
				<ORIGINAL_TEXT>Despite that, it has been used in several African countries since 2015.</ORIGINAL_TEXT>
				<TOKEN id="token-6-0" start_char="757" end_char="763">Despite</TOKEN>
				<TOKEN id="token-6-1" start_char="765" end_char="768">that</TOKEN>
				<TOKEN id="token-6-2" start_char="769" end_char="769">,</TOKEN>
				<TOKEN id="token-6-3" start_char="771" end_char="772">it</TOKEN>
				<TOKEN id="token-6-4" start_char="774" end_char="776">has</TOKEN>
				<TOKEN id="token-6-5" start_char="778" end_char="781">been</TOKEN>
				<TOKEN id="token-6-6" start_char="783" end_char="786">used</TOKEN>
				<TOKEN id="token-6-7" start_char="788" end_char="789">in</TOKEN>
				<TOKEN id="token-6-8" start_char="791" end_char="797">several</TOKEN>
				<TOKEN id="token-6-9" start_char="799" end_char="805">African</TOKEN>
				<TOKEN id="token-6-10" start_char="807" end_char="815">countries</TOKEN>
				<TOKEN id="token-6-11" start_char="817" end_char="821">since</TOKEN>
				<TOKEN id="token-6-12" start_char="823" end_char="826">2015</TOKEN>
				<TOKEN id="token-6-13" start_char="827" end_char="827">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-7" start_char="829" end_char="922">
				<ORIGINAL_TEXT>The drug received international attention after being named as a potential COVID-19 treatment.</ORIGINAL_TEXT>
				<TOKEN id="token-7-0" start_char="829" end_char="831">The</TOKEN>
				<TOKEN id="token-7-1" start_char="833" end_char="836">drug</TOKEN>
				<TOKEN id="token-7-2" start_char="838" end_char="845">received</TOKEN>
				<TOKEN id="token-7-3" start_char="847" end_char="859">international</TOKEN>
				<TOKEN id="token-7-4" start_char="861" end_char="869">attention</TOKEN>
				<TOKEN id="token-7-5" start_char="871" end_char="875">after</TOKEN>
				<TOKEN id="token-7-6" start_char="877" end_char="881">being</TOKEN>
				<TOKEN id="token-7-7" start_char="883" end_char="887">named</TOKEN>
				<TOKEN id="token-7-8" start_char="889" end_char="890">as</TOKEN>
				<TOKEN id="token-7-9" start_char="892" end_char="892">a</TOKEN>
				<TOKEN id="token-7-10" start_char="894" end_char="902">potential</TOKEN>
				<TOKEN id="token-7-11" start_char="904" end_char="908">COVID</TOKEN>
				<TOKEN id="token-7-12" start_char="909" end_char="909">-</TOKEN>
				<TOKEN id="token-7-13" start_char="910" end_char="911">19</TOKEN>
				<TOKEN id="token-7-14" start_char="913" end_char="921">treatment</TOKEN>
				<TOKEN id="token-7-15" start_char="922" end_char="922">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-8" start_char="924" end_char="1091">
				<ORIGINAL_TEXT>U.S. President Donald Trump highlighted remdesivir in mid-March, and his administration said it is expanding access to the medication to fight the coronavirus pandemic.</ORIGINAL_TEXT>
				<TOKEN id="token-8-0" start_char="924" end_char="924">U</TOKEN>
				<TOKEN id="token-8-1" start_char="925" end_char="925">.</TOKEN>
				<TOKEN id="token-8-2" start_char="926" end_char="926">S</TOKEN>
				<TOKEN id="token-8-3" start_char="927" end_char="927">.</TOKEN>
				<TOKEN id="token-8-4" start_char="929" end_char="937">President</TOKEN>
				<TOKEN id="token-8-5" start_char="939" end_char="944">Donald</TOKEN>
				<TOKEN id="token-8-6" start_char="946" end_char="950">Trump</TOKEN>
				<TOKEN id="token-8-7" start_char="952" end_char="962">highlighted</TOKEN>
				<TOKEN id="token-8-8" start_char="964" end_char="973">remdesivir</TOKEN>
				<TOKEN id="token-8-9" start_char="975" end_char="976">in</TOKEN>
				<TOKEN id="token-8-10" start_char="978" end_char="980">mid</TOKEN>
				<TOKEN id="token-8-11" start_char="981" end_char="981">-</TOKEN>
				<TOKEN id="token-8-12" start_char="982" end_char="986">March</TOKEN>
				<TOKEN id="token-8-13" start_char="987" end_char="987">,</TOKEN>
				<TOKEN id="token-8-14" start_char="989" end_char="991">and</TOKEN>
				<TOKEN id="token-8-15" start_char="993" end_char="995">his</TOKEN>
				<TOKEN id="token-8-16" start_char="997" end_char="1010">administration</TOKEN>
				<TOKEN id="token-8-17" start_char="1012" end_char="1015">said</TOKEN>
				<TOKEN id="token-8-18" start_char="1017" end_char="1018">it</TOKEN>
				<TOKEN id="token-8-19" start_char="1020" end_char="1021">is</TOKEN>
				<TOKEN id="token-8-20" start_char="1023" end_char="1031">expanding</TOKEN>
				<TOKEN id="token-8-21" start_char="1033" end_char="1038">access</TOKEN>
				<TOKEN id="token-8-22" start_char="1040" end_char="1041">to</TOKEN>
				<TOKEN id="token-8-23" start_char="1043" end_char="1045">the</TOKEN>
				<TOKEN id="token-8-24" start_char="1047" end_char="1056">medication</TOKEN>
				<TOKEN id="token-8-25" start_char="1058" end_char="1059">to</TOKEN>
				<TOKEN id="token-8-26" start_char="1061" end_char="1065">fight</TOKEN>
				<TOKEN id="token-8-27" start_char="1067" end_char="1069">the</TOKEN>
				<TOKEN id="token-8-28" start_char="1071" end_char="1081">coronavirus</TOKEN>
				<TOKEN id="token-8-29" start_char="1083" end_char="1090">pandemic</TOKEN>
				<TOKEN id="token-8-30" start_char="1091" end_char="1091">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-9" start_char="1093" end_char="1304">
				<ORIGINAL_TEXT>On April 29, the U.S. National Institute of Allergy and Infectious Diseases (NIAID) released a statement on a preliminary data analysis of a remdesivir trial that began on February 21 and involved 1,063 patients.</ORIGINAL_TEXT>
				<TOKEN id="token-9-0" start_char="1093" end_char="1094">On</TOKEN>
				<TOKEN id="token-9-1" start_char="1096" end_char="1100">April</TOKEN>
				<TOKEN id="token-9-2" start_char="1102" end_char="1103">29</TOKEN>
				<TOKEN id="token-9-3" start_char="1104" end_char="1104">,</TOKEN>
				<TOKEN id="token-9-4" start_char="1106" end_char="1108">the</TOKEN>
				<TOKEN id="token-9-5" start_char="1110" end_char="1110">U</TOKEN>
				<TOKEN id="token-9-6" start_char="1111" end_char="1111">.</TOKEN>
				<TOKEN id="token-9-7" start_char="1112" end_char="1112">S</TOKEN>
				<TOKEN id="token-9-8" start_char="1113" end_char="1113">.</TOKEN>
				<TOKEN id="token-9-9" start_char="1115" end_char="1122">National</TOKEN>
				<TOKEN id="token-9-10" start_char="1124" end_char="1132">Institute</TOKEN>
				<TOKEN id="token-9-11" start_char="1134" end_char="1135">of</TOKEN>
				<TOKEN id="token-9-12" start_char="1137" end_char="1143">Allergy</TOKEN>
				<TOKEN id="token-9-13" start_char="1145" end_char="1147">and</TOKEN>
				<TOKEN id="token-9-14" start_char="1149" end_char="1158">Infectious</TOKEN>
				<TOKEN id="token-9-15" start_char="1160" end_char="1167">Diseases</TOKEN>
				<TOKEN id="token-9-16" start_char="1169" end_char="1169">(</TOKEN>
				<TOKEN id="token-9-17" start_char="1170" end_char="1174">NIAID</TOKEN>
				<TOKEN id="token-9-18" start_char="1175" end_char="1175">)</TOKEN>
				<TOKEN id="token-9-19" start_char="1177" end_char="1184">released</TOKEN>
				<TOKEN id="token-9-20" start_char="1186" end_char="1186">a</TOKEN>
				<TOKEN id="token-9-21" start_char="1188" end_char="1196">statement</TOKEN>
				<TOKEN id="token-9-22" start_char="1198" end_char="1199">on</TOKEN>
				<TOKEN id="token-9-23" start_char="1201" end_char="1201">a</TOKEN>
				<TOKEN id="token-9-24" start_char="1203" end_char="1213">preliminary</TOKEN>
				<TOKEN id="token-9-25" start_char="1215" end_char="1218">data</TOKEN>
				<TOKEN id="token-9-26" start_char="1220" end_char="1227">analysis</TOKEN>
				<TOKEN id="token-9-27" start_char="1229" end_char="1230">of</TOKEN>
				<TOKEN id="token-9-28" start_char="1232" end_char="1232">a</TOKEN>
				<TOKEN id="token-9-29" start_char="1234" end_char="1243">remdesivir</TOKEN>
				<TOKEN id="token-9-30" start_char="1245" end_char="1249">trial</TOKEN>
				<TOKEN id="token-9-31" start_char="1251" end_char="1254">that</TOKEN>
				<TOKEN id="token-9-32" start_char="1256" end_char="1260">began</TOKEN>
				<TOKEN id="token-9-33" start_char="1262" end_char="1263">on</TOKEN>
				<TOKEN id="token-9-34" start_char="1265" end_char="1272">February</TOKEN>
				<TOKEN id="token-9-35" start_char="1274" end_char="1275">21</TOKEN>
				<TOKEN id="token-9-36" start_char="1277" end_char="1279">and</TOKEN>
				<TOKEN id="token-9-37" start_char="1281" end_char="1288">involved</TOKEN>
				<TOKEN id="token-9-38" start_char="1290" end_char="1290">1</TOKEN>
				<TOKEN id="token-9-39" start_char="1291" end_char="1291">,</TOKEN>
				<TOKEN id="token-9-40" start_char="1292" end_char="1294">063</TOKEN>
				<TOKEN id="token-9-41" start_char="1296" end_char="1303">patients</TOKEN>
				<TOKEN id="token-9-42" start_char="1304" end_char="1304">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-10" start_char="1306" end_char="1481">
				<ORIGINAL_TEXT>It found a 31 percent faster recovery time for patients with advanced COVID-19 and lung involvement who received remdesivir compared to similar patients who received a placebo.</ORIGINAL_TEXT>
				<TOKEN id="token-10-0" start_char="1306" end_char="1307">It</TOKEN>
				<TOKEN id="token-10-1" start_char="1309" end_char="1313">found</TOKEN>
				<TOKEN id="token-10-2" start_char="1315" end_char="1315">a</TOKEN>
				<TOKEN id="token-10-3" start_char="1317" end_char="1318">31</TOKEN>
				<TOKEN id="token-10-4" start_char="1320" end_char="1326">percent</TOKEN>
				<TOKEN id="token-10-5" start_char="1328" end_char="1333">faster</TOKEN>
				<TOKEN id="token-10-6" start_char="1335" end_char="1342">recovery</TOKEN>
				<TOKEN id="token-10-7" start_char="1344" end_char="1347">time</TOKEN>
				<TOKEN id="token-10-8" start_char="1349" end_char="1351">for</TOKEN>
				<TOKEN id="token-10-9" start_char="1353" end_char="1360">patients</TOKEN>
				<TOKEN id="token-10-10" start_char="1362" end_char="1365">with</TOKEN>
				<TOKEN id="token-10-11" start_char="1367" end_char="1374">advanced</TOKEN>
				<TOKEN id="token-10-12" start_char="1376" end_char="1380">COVID</TOKEN>
				<TOKEN id="token-10-13" start_char="1381" end_char="1381">-</TOKEN>
				<TOKEN id="token-10-14" start_char="1382" end_char="1383">19</TOKEN>
				<TOKEN id="token-10-15" start_char="1385" end_char="1387">and</TOKEN>
				<TOKEN id="token-10-16" start_char="1389" end_char="1392">lung</TOKEN>
				<TOKEN id="token-10-17" start_char="1394" end_char="1404">involvement</TOKEN>
				<TOKEN id="token-10-18" start_char="1406" end_char="1408">who</TOKEN>
				<TOKEN id="token-10-19" start_char="1410" end_char="1417">received</TOKEN>
				<TOKEN id="token-10-20" start_char="1419" end_char="1428">remdesivir</TOKEN>
				<TOKEN id="token-10-21" start_char="1430" end_char="1437">compared</TOKEN>
				<TOKEN id="token-10-22" start_char="1439" end_char="1440">to</TOKEN>
				<TOKEN id="token-10-23" start_char="1442" end_char="1448">similar</TOKEN>
				<TOKEN id="token-10-24" start_char="1450" end_char="1457">patients</TOKEN>
				<TOKEN id="token-10-25" start_char="1459" end_char="1461">who</TOKEN>
				<TOKEN id="token-10-26" start_char="1463" end_char="1470">received</TOKEN>
				<TOKEN id="token-10-27" start_char="1472" end_char="1472">a</TOKEN>
				<TOKEN id="token-10-28" start_char="1474" end_char="1480">placebo</TOKEN>
				<TOKEN id="token-10-29" start_char="1481" end_char="1481">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-11" start_char="1483" end_char="1618">
				<ORIGINAL_TEXT>The data also showed a lower mortality rate among patients receiving remdesivir: 8 percent compared to 11.6 percent among placebo group.</ORIGINAL_TEXT>
				<TOKEN id="token-11-0" start_char="1483" end_char="1485">The</TOKEN>
				<TOKEN id="token-11-1" start_char="1487" end_char="1490">data</TOKEN>
				<TOKEN id="token-11-2" start_char="1492" end_char="1495">also</TOKEN>
				<TOKEN id="token-11-3" start_char="1497" end_char="1502">showed</TOKEN>
				<TOKEN id="token-11-4" start_char="1504" end_char="1504">a</TOKEN>
				<TOKEN id="token-11-5" start_char="1506" end_char="1510">lower</TOKEN>
				<TOKEN id="token-11-6" start_char="1512" end_char="1520">mortality</TOKEN>
				<TOKEN id="token-11-7" start_char="1522" end_char="1525">rate</TOKEN>
				<TOKEN id="token-11-8" start_char="1527" end_char="1531">among</TOKEN>
				<TOKEN id="token-11-9" start_char="1533" end_char="1540">patients</TOKEN>
				<TOKEN id="token-11-10" start_char="1542" end_char="1550">receiving</TOKEN>
				<TOKEN id="token-11-11" start_char="1552" end_char="1561">remdesivir</TOKEN>
				<TOKEN id="token-11-12" start_char="1562" end_char="1562">:</TOKEN>
				<TOKEN id="token-11-13" start_char="1564" end_char="1564">8</TOKEN>
				<TOKEN id="token-11-14" start_char="1566" end_char="1572">percent</TOKEN>
				<TOKEN id="token-11-15" start_char="1574" end_char="1581">compared</TOKEN>
				<TOKEN id="token-11-16" start_char="1583" end_char="1584">to</TOKEN>
				<TOKEN id="token-11-17" start_char="1586" end_char="1587">11</TOKEN>
				<TOKEN id="token-11-18" start_char="1588" end_char="1588">.</TOKEN>
				<TOKEN id="token-11-19" start_char="1589" end_char="1589">6</TOKEN>
				<TOKEN id="token-11-20" start_char="1591" end_char="1597">percent</TOKEN>
				<TOKEN id="token-11-21" start_char="1599" end_char="1603">among</TOKEN>
				<TOKEN id="token-11-22" start_char="1605" end_char="1611">placebo</TOKEN>
				<TOKEN id="token-11-23" start_char="1613" end_char="1617">group</TOKEN>
				<TOKEN id="token-11-24" start_char="1618" end_char="1618">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-12" start_char="1620" end_char="1796">
				<ORIGINAL_TEXT>Also, on Wednesday, April 29, Gilead Sciences released preliminary results of its coronavirus drug trial, which involved 397 hospitalized patients with severe cases of COVID-19.</ORIGINAL_TEXT>
				<TOKEN id="token-12-0" start_char="1620" end_char="1623">Also</TOKEN>
				<TOKEN id="token-12-1" start_char="1624" end_char="1624">,</TOKEN>
				<TOKEN id="token-12-2" start_char="1626" end_char="1627">on</TOKEN>
				<TOKEN id="token-12-3" start_char="1629" end_char="1637">Wednesday</TOKEN>
				<TOKEN id="token-12-4" start_char="1638" end_char="1638">,</TOKEN>
				<TOKEN id="token-12-5" start_char="1640" end_char="1644">April</TOKEN>
				<TOKEN id="token-12-6" start_char="1646" end_char="1647">29</TOKEN>
				<TOKEN id="token-12-7" start_char="1648" end_char="1648">,</TOKEN>
				<TOKEN id="token-12-8" start_char="1650" end_char="1655">Gilead</TOKEN>
				<TOKEN id="token-12-9" start_char="1657" end_char="1664">Sciences</TOKEN>
				<TOKEN id="token-12-10" start_char="1666" end_char="1673">released</TOKEN>
				<TOKEN id="token-12-11" start_char="1675" end_char="1685">preliminary</TOKEN>
				<TOKEN id="token-12-12" start_char="1687" end_char="1693">results</TOKEN>
				<TOKEN id="token-12-13" start_char="1695" end_char="1696">of</TOKEN>
				<TOKEN id="token-12-14" start_char="1698" end_char="1700">its</TOKEN>
				<TOKEN id="token-12-15" start_char="1702" end_char="1712">coronavirus</TOKEN>
				<TOKEN id="token-12-16" start_char="1714" end_char="1717">drug</TOKEN>
				<TOKEN id="token-12-17" start_char="1719" end_char="1723">trial</TOKEN>
				<TOKEN id="token-12-18" start_char="1724" end_char="1724">,</TOKEN>
				<TOKEN id="token-12-19" start_char="1726" end_char="1730">which</TOKEN>
				<TOKEN id="token-12-20" start_char="1732" end_char="1739">involved</TOKEN>
				<TOKEN id="token-12-21" start_char="1741" end_char="1743">397</TOKEN>
				<TOKEN id="token-12-22" start_char="1745" end_char="1756">hospitalized</TOKEN>
				<TOKEN id="token-12-23" start_char="1758" end_char="1765">patients</TOKEN>
				<TOKEN id="token-12-24" start_char="1767" end_char="1770">with</TOKEN>
				<TOKEN id="token-12-25" start_char="1772" end_char="1777">severe</TOKEN>
				<TOKEN id="token-12-26" start_char="1779" end_char="1783">cases</TOKEN>
				<TOKEN id="token-12-27" start_char="1785" end_char="1786">of</TOKEN>
				<TOKEN id="token-12-28" start_char="1788" end_char="1792">COVID</TOKEN>
				<TOKEN id="token-12-29" start_char="1793" end_char="1793">-</TOKEN>
				<TOKEN id="token-12-30" start_char="1794" end_char="1795">19</TOKEN>
				<TOKEN id="token-12-31" start_char="1796" end_char="1796">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-13" start_char="1798" end_char="1876">
				<ORIGINAL_TEXT>They were divided into two groups taking remdesivir for either five or 10 days.</ORIGINAL_TEXT>
				<TOKEN id="token-13-0" start_char="1798" end_char="1801">They</TOKEN>
				<TOKEN id="token-13-1" start_char="1803" end_char="1806">were</TOKEN>
				<TOKEN id="token-13-2" start_char="1808" end_char="1814">divided</TOKEN>
				<TOKEN id="token-13-3" start_char="1816" end_char="1819">into</TOKEN>
				<TOKEN id="token-13-4" start_char="1821" end_char="1823">two</TOKEN>
				<TOKEN id="token-13-5" start_char="1825" end_char="1830">groups</TOKEN>
				<TOKEN id="token-13-6" start_char="1832" end_char="1837">taking</TOKEN>
				<TOKEN id="token-13-7" start_char="1839" end_char="1848">remdesivir</TOKEN>
				<TOKEN id="token-13-8" start_char="1850" end_char="1852">for</TOKEN>
				<TOKEN id="token-13-9" start_char="1854" end_char="1859">either</TOKEN>
				<TOKEN id="token-13-10" start_char="1861" end_char="1864">five</TOKEN>
				<TOKEN id="token-13-11" start_char="1866" end_char="1867">or</TOKEN>
				<TOKEN id="token-13-12" start_char="1869" end_char="1870">10</TOKEN>
				<TOKEN id="token-13-13" start_char="1872" end_char="1875">days</TOKEN>
				<TOKEN id="token-13-14" start_char="1876" end_char="1876">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-14" start_char="1878" end_char="1982">
				<ORIGINAL_TEXT>More than half of the patients in both treatment groups were discharged from the hospital within 14 days.</ORIGINAL_TEXT>
				<TOKEN id="token-14-0" start_char="1878" end_char="1881">More</TOKEN>
				<TOKEN id="token-14-1" start_char="1883" end_char="1886">than</TOKEN>
				<TOKEN id="token-14-2" start_char="1888" end_char="1891">half</TOKEN>
				<TOKEN id="token-14-3" start_char="1893" end_char="1894">of</TOKEN>
				<TOKEN id="token-14-4" start_char="1896" end_char="1898">the</TOKEN>
				<TOKEN id="token-14-5" start_char="1900" end_char="1907">patients</TOKEN>
				<TOKEN id="token-14-6" start_char="1909" end_char="1910">in</TOKEN>
				<TOKEN id="token-14-7" start_char="1912" end_char="1915">both</TOKEN>
				<TOKEN id="token-14-8" start_char="1917" end_char="1925">treatment</TOKEN>
				<TOKEN id="token-14-9" start_char="1927" end_char="1932">groups</TOKEN>
				<TOKEN id="token-14-10" start_char="1934" end_char="1937">were</TOKEN>
				<TOKEN id="token-14-11" start_char="1939" end_char="1948">discharged</TOKEN>
				<TOKEN id="token-14-12" start_char="1950" end_char="1953">from</TOKEN>
				<TOKEN id="token-14-13" start_char="1955" end_char="1957">the</TOKEN>
				<TOKEN id="token-14-14" start_char="1959" end_char="1966">hospital</TOKEN>
				<TOKEN id="token-14-15" start_char="1968" end_char="1973">within</TOKEN>
				<TOKEN id="token-14-16" start_char="1975" end_char="1976">14</TOKEN>
				<TOKEN id="token-14-17" start_char="1978" end_char="1981">days</TOKEN>
				<TOKEN id="token-14-18" start_char="1982" end_char="1982">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-15" start_char="1984" end_char="2067">
				<ORIGINAL_TEXT>This study did not evaluate remdesivir against a control group not getting the drug.</ORIGINAL_TEXT>
				<TOKEN id="token-15-0" start_char="1984" end_char="1987">This</TOKEN>
				<TOKEN id="token-15-1" start_char="1989" end_char="1993">study</TOKEN>
				<TOKEN id="token-15-2" start_char="1995" end_char="1997">did</TOKEN>
				<TOKEN id="token-15-3" start_char="1999" end_char="2001">not</TOKEN>
				<TOKEN id="token-15-4" start_char="2003" end_char="2010">evaluate</TOKEN>
				<TOKEN id="token-15-5" start_char="2012" end_char="2021">remdesivir</TOKEN>
				<TOKEN id="token-15-6" start_char="2023" end_char="2029">against</TOKEN>
				<TOKEN id="token-15-7" start_char="2031" end_char="2031">a</TOKEN>
				<TOKEN id="token-15-8" start_char="2033" end_char="2039">control</TOKEN>
				<TOKEN id="token-15-9" start_char="2041" end_char="2045">group</TOKEN>
				<TOKEN id="token-15-10" start_char="2047" end_char="2049">not</TOKEN>
				<TOKEN id="token-15-11" start_char="2051" end_char="2057">getting</TOKEN>
				<TOKEN id="token-15-12" start_char="2059" end_char="2061">the</TOKEN>
				<TOKEN id="token-15-13" start_char="2063" end_char="2066">drug</TOKEN>
				<TOKEN id="token-15-14" start_char="2067" end_char="2067">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-16" start_char="2069" end_char="2215">
				<ORIGINAL_TEXT>Although the News Front Georgia article was published prior to these new study results, the website mischaracterized the results of earlier trials.</ORIGINAL_TEXT>
				<TOKEN id="token-16-0" start_char="2069" end_char="2076">Although</TOKEN>
				<TOKEN id="token-16-1" start_char="2078" end_char="2080">the</TOKEN>
				<TOKEN id="token-16-2" start_char="2082" end_char="2085">News</TOKEN>
				<TOKEN id="token-16-3" start_char="2087" end_char="2091">Front</TOKEN>
				<TOKEN id="token-16-4" start_char="2093" end_char="2099">Georgia</TOKEN>
				<TOKEN id="token-16-5" start_char="2101" end_char="2107">article</TOKEN>
				<TOKEN id="token-16-6" start_char="2109" end_char="2111">was</TOKEN>
				<TOKEN id="token-16-7" start_char="2113" end_char="2121">published</TOKEN>
				<TOKEN id="token-16-8" start_char="2123" end_char="2127">prior</TOKEN>
				<TOKEN id="token-16-9" start_char="2129" end_char="2130">to</TOKEN>
				<TOKEN id="token-16-10" start_char="2132" end_char="2136">these</TOKEN>
				<TOKEN id="token-16-11" start_char="2138" end_char="2140">new</TOKEN>
				<TOKEN id="token-16-12" start_char="2142" end_char="2146">study</TOKEN>
				<TOKEN id="token-16-13" start_char="2148" end_char="2154">results</TOKEN>
				<TOKEN id="token-16-14" start_char="2155" end_char="2155">,</TOKEN>
				<TOKEN id="token-16-15" start_char="2157" end_char="2159">the</TOKEN>
				<TOKEN id="token-16-16" start_char="2161" end_char="2167">website</TOKEN>
				<TOKEN id="token-16-17" start_char="2169" end_char="2184">mischaracterized</TOKEN>
				<TOKEN id="token-16-18" start_char="2186" end_char="2188">the</TOKEN>
				<TOKEN id="token-16-19" start_char="2190" end_char="2196">results</TOKEN>
				<TOKEN id="token-16-20" start_char="2198" end_char="2199">of</TOKEN>
				<TOKEN id="token-16-21" start_char="2201" end_char="2207">earlier</TOKEN>
				<TOKEN id="token-16-22" start_char="2209" end_char="2214">trials</TOKEN>
				<TOKEN id="token-16-23" start_char="2215" end_char="2215">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-17" start_char="2217" end_char="2462">
				<ORIGINAL_TEXT>“The first clinical trial on remdesivir, an experimental medication of the company Gilead Sciences, which has been seen as one of the promising and most successful medications in treating coronavirus, proved a failure“ News Front Georgia claimed.</ORIGINAL_TEXT>
				<TOKEN id="token-17-0" start_char="2217" end_char="2217">“</TOKEN>
				<TOKEN id="token-17-1" start_char="2218" end_char="2220">The</TOKEN>
				<TOKEN id="token-17-2" start_char="2222" end_char="2226">first</TOKEN>
				<TOKEN id="token-17-3" start_char="2228" end_char="2235">clinical</TOKEN>
				<TOKEN id="token-17-4" start_char="2237" end_char="2241">trial</TOKEN>
				<TOKEN id="token-17-5" start_char="2243" end_char="2244">on</TOKEN>
				<TOKEN id="token-17-6" start_char="2246" end_char="2255">remdesivir</TOKEN>
				<TOKEN id="token-17-7" start_char="2256" end_char="2256">,</TOKEN>
				<TOKEN id="token-17-8" start_char="2258" end_char="2259">an</TOKEN>
				<TOKEN id="token-17-9" start_char="2261" end_char="2272">experimental</TOKEN>
				<TOKEN id="token-17-10" start_char="2274" end_char="2283">medication</TOKEN>
				<TOKEN id="token-17-11" start_char="2285" end_char="2286">of</TOKEN>
				<TOKEN id="token-17-12" start_char="2288" end_char="2290">the</TOKEN>
				<TOKEN id="token-17-13" start_char="2292" end_char="2298">company</TOKEN>
				<TOKEN id="token-17-14" start_char="2300" end_char="2305">Gilead</TOKEN>
				<TOKEN id="token-17-15" start_char="2307" end_char="2314">Sciences</TOKEN>
				<TOKEN id="token-17-16" start_char="2315" end_char="2315">,</TOKEN>
				<TOKEN id="token-17-17" start_char="2317" end_char="2321">which</TOKEN>
				<TOKEN id="token-17-18" start_char="2323" end_char="2325">has</TOKEN>
				<TOKEN id="token-17-19" start_char="2327" end_char="2330">been</TOKEN>
				<TOKEN id="token-17-20" start_char="2332" end_char="2335">seen</TOKEN>
				<TOKEN id="token-17-21" start_char="2337" end_char="2338">as</TOKEN>
				<TOKEN id="token-17-22" start_char="2340" end_char="2342">one</TOKEN>
				<TOKEN id="token-17-23" start_char="2344" end_char="2345">of</TOKEN>
				<TOKEN id="token-17-24" start_char="2347" end_char="2349">the</TOKEN>
				<TOKEN id="token-17-25" start_char="2351" end_char="2359">promising</TOKEN>
				<TOKEN id="token-17-26" start_char="2361" end_char="2363">and</TOKEN>
				<TOKEN id="token-17-27" start_char="2365" end_char="2368">most</TOKEN>
				<TOKEN id="token-17-28" start_char="2370" end_char="2379">successful</TOKEN>
				<TOKEN id="token-17-29" start_char="2381" end_char="2391">medications</TOKEN>
				<TOKEN id="token-17-30" start_char="2393" end_char="2394">in</TOKEN>
				<TOKEN id="token-17-31" start_char="2396" end_char="2403">treating</TOKEN>
				<TOKEN id="token-17-32" start_char="2405" end_char="2415">coronavirus</TOKEN>
				<TOKEN id="token-17-33" start_char="2416" end_char="2416">,</TOKEN>
				<TOKEN id="token-17-34" start_char="2418" end_char="2423">proved</TOKEN>
				<TOKEN id="token-17-35" start_char="2425" end_char="2425">a</TOKEN>
				<TOKEN id="token-17-36" start_char="2427" end_char="2433">failure</TOKEN>
				<TOKEN id="token-17-37" start_char="2434" end_char="2434">“</TOKEN>
				<TOKEN id="token-17-38" start_char="2436" end_char="2439">News</TOKEN>
				<TOKEN id="token-17-39" start_char="2441" end_char="2445">Front</TOKEN>
				<TOKEN id="token-17-40" start_char="2447" end_char="2453">Georgia</TOKEN>
				<TOKEN id="token-17-41" start_char="2455" end_char="2461">claimed</TOKEN>
				<TOKEN id="token-17-42" start_char="2462" end_char="2462">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-18" start_char="2464" end_char="2717">
				<ORIGINAL_TEXT>Citing a Financial Times report, News Front Georgia said a WHO study conducted by Chinese scientists found that remdesivir did not improve the condition of COVID-19 patients or decrease the amount of the novel coronavirus, SARS-Cov-2, in the bloodstream.</ORIGINAL_TEXT>
				<TOKEN id="token-18-0" start_char="2464" end_char="2469">Citing</TOKEN>
				<TOKEN id="token-18-1" start_char="2471" end_char="2471">a</TOKEN>
				<TOKEN id="token-18-2" start_char="2473" end_char="2481">Financial</TOKEN>
				<TOKEN id="token-18-3" start_char="2483" end_char="2487">Times</TOKEN>
				<TOKEN id="token-18-4" start_char="2489" end_char="2494">report</TOKEN>
				<TOKEN id="token-18-5" start_char="2495" end_char="2495">,</TOKEN>
				<TOKEN id="token-18-6" start_char="2497" end_char="2500">News</TOKEN>
				<TOKEN id="token-18-7" start_char="2502" end_char="2506">Front</TOKEN>
				<TOKEN id="token-18-8" start_char="2508" end_char="2514">Georgia</TOKEN>
				<TOKEN id="token-18-9" start_char="2516" end_char="2519">said</TOKEN>
				<TOKEN id="token-18-10" start_char="2521" end_char="2521">a</TOKEN>
				<TOKEN id="token-18-11" start_char="2523" end_char="2525">WHO</TOKEN>
				<TOKEN id="token-18-12" start_char="2527" end_char="2531">study</TOKEN>
				<TOKEN id="token-18-13" start_char="2533" end_char="2541">conducted</TOKEN>
				<TOKEN id="token-18-14" start_char="2543" end_char="2544">by</TOKEN>
				<TOKEN id="token-18-15" start_char="2546" end_char="2552">Chinese</TOKEN>
				<TOKEN id="token-18-16" start_char="2554" end_char="2563">scientists</TOKEN>
				<TOKEN id="token-18-17" start_char="2565" end_char="2569">found</TOKEN>
				<TOKEN id="token-18-18" start_char="2571" end_char="2574">that</TOKEN>
				<TOKEN id="token-18-19" start_char="2576" end_char="2585">remdesivir</TOKEN>
				<TOKEN id="token-18-20" start_char="2587" end_char="2589">did</TOKEN>
				<TOKEN id="token-18-21" start_char="2591" end_char="2593">not</TOKEN>
				<TOKEN id="token-18-22" start_char="2595" end_char="2601">improve</TOKEN>
				<TOKEN id="token-18-23" start_char="2603" end_char="2605">the</TOKEN>
				<TOKEN id="token-18-24" start_char="2607" end_char="2615">condition</TOKEN>
				<TOKEN id="token-18-25" start_char="2617" end_char="2618">of</TOKEN>
				<TOKEN id="token-18-26" start_char="2620" end_char="2624">COVID</TOKEN>
				<TOKEN id="token-18-27" start_char="2625" end_char="2625">-</TOKEN>
				<TOKEN id="token-18-28" start_char="2626" end_char="2627">19</TOKEN>
				<TOKEN id="token-18-29" start_char="2629" end_char="2636">patients</TOKEN>
				<TOKEN id="token-18-30" start_char="2638" end_char="2639">or</TOKEN>
				<TOKEN id="token-18-31" start_char="2641" end_char="2648">decrease</TOKEN>
				<TOKEN id="token-18-32" start_char="2650" end_char="2652">the</TOKEN>
				<TOKEN id="token-18-33" start_char="2654" end_char="2659">amount</TOKEN>
				<TOKEN id="token-18-34" start_char="2661" end_char="2662">of</TOKEN>
				<TOKEN id="token-18-35" start_char="2664" end_char="2666">the</TOKEN>
				<TOKEN id="token-18-36" start_char="2668" end_char="2672">novel</TOKEN>
				<TOKEN id="token-18-37" start_char="2674" end_char="2684">coronavirus</TOKEN>
				<TOKEN id="token-18-38" start_char="2685" end_char="2685">,</TOKEN>
				<TOKEN id="token-18-39" start_char="2687" end_char="2690">SARS</TOKEN>
				<TOKEN id="token-18-40" start_char="2691" end_char="2691">-</TOKEN>
				<TOKEN id="token-18-41" start_char="2692" end_char="2694">Cov</TOKEN>
				<TOKEN id="token-18-42" start_char="2695" end_char="2695">-</TOKEN>
				<TOKEN id="token-18-43" start_char="2696" end_char="2696">2</TOKEN>
				<TOKEN id="token-18-44" start_char="2697" end_char="2697">,</TOKEN>
				<TOKEN id="token-18-45" start_char="2699" end_char="2700">in</TOKEN>
				<TOKEN id="token-18-46" start_char="2702" end_char="2704">the</TOKEN>
				<TOKEN id="token-18-47" start_char="2706" end_char="2716">bloodstream</TOKEN>
				<TOKEN id="token-18-48" start_char="2717" end_char="2717">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-19" start_char="2719" end_char="2828">
				<ORIGINAL_TEXT>In fact, the clinical trial that News Front Georgia referred to was neither the first nor the only such trial.</ORIGINAL_TEXT>
				<TOKEN id="token-19-0" start_char="2719" end_char="2720">In</TOKEN>
				<TOKEN id="token-19-1" start_char="2722" end_char="2725">fact</TOKEN>
				<TOKEN id="token-19-2" start_char="2726" end_char="2726">,</TOKEN>
				<TOKEN id="token-19-3" start_char="2728" end_char="2730">the</TOKEN>
				<TOKEN id="token-19-4" start_char="2732" end_char="2739">clinical</TOKEN>
				<TOKEN id="token-19-5" start_char="2741" end_char="2745">trial</TOKEN>
				<TOKEN id="token-19-6" start_char="2747" end_char="2750">that</TOKEN>
				<TOKEN id="token-19-7" start_char="2752" end_char="2755">News</TOKEN>
				<TOKEN id="token-19-8" start_char="2757" end_char="2761">Front</TOKEN>
				<TOKEN id="token-19-9" start_char="2763" end_char="2769">Georgia</TOKEN>
				<TOKEN id="token-19-10" start_char="2771" end_char="2778">referred</TOKEN>
				<TOKEN id="token-19-11" start_char="2780" end_char="2781">to</TOKEN>
				<TOKEN id="token-19-12" start_char="2783" end_char="2785">was</TOKEN>
				<TOKEN id="token-19-13" start_char="2787" end_char="2793">neither</TOKEN>
				<TOKEN id="token-19-14" start_char="2795" end_char="2797">the</TOKEN>
				<TOKEN id="token-19-15" start_char="2799" end_char="2803">first</TOKEN>
				<TOKEN id="token-19-16" start_char="2805" end_char="2807">nor</TOKEN>
				<TOKEN id="token-19-17" start_char="2809" end_char="2811">the</TOKEN>
				<TOKEN id="token-19-18" start_char="2813" end_char="2816">only</TOKEN>
				<TOKEN id="token-19-19" start_char="2818" end_char="2821">such</TOKEN>
				<TOKEN id="token-19-20" start_char="2823" end_char="2827">trial</TOKEN>
				<TOKEN id="token-19-21" start_char="2828" end_char="2828">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-20" start_char="2830" end_char="2897">
				<ORIGINAL_TEXT>There was an earlier clinical trial, and several others are ongoing.</ORIGINAL_TEXT>
				<TOKEN id="token-20-0" start_char="2830" end_char="2834">There</TOKEN>
				<TOKEN id="token-20-1" start_char="2836" end_char="2838">was</TOKEN>
				<TOKEN id="token-20-2" start_char="2840" end_char="2841">an</TOKEN>
				<TOKEN id="token-20-3" start_char="2843" end_char="2849">earlier</TOKEN>
				<TOKEN id="token-20-4" start_char="2851" end_char="2858">clinical</TOKEN>
				<TOKEN id="token-20-5" start_char="2860" end_char="2864">trial</TOKEN>
				<TOKEN id="token-20-6" start_char="2865" end_char="2865">,</TOKEN>
				<TOKEN id="token-20-7" start_char="2867" end_char="2869">and</TOKEN>
				<TOKEN id="token-20-8" start_char="2871" end_char="2877">several</TOKEN>
				<TOKEN id="token-20-9" start_char="2879" end_char="2884">others</TOKEN>
				<TOKEN id="token-20-10" start_char="2886" end_char="2888">are</TOKEN>
				<TOKEN id="token-20-11" start_char="2890" end_char="2896">ongoing</TOKEN>
				<TOKEN id="token-20-12" start_char="2897" end_char="2897">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-21" start_char="2899" end_char="3066">
				<ORIGINAL_TEXT>The first clinical trial of remdesivir on COVID-19 patients in serious condition was conducted by the University of Chicago Medicine and received some positive reviews.</ORIGINAL_TEXT>
				<TOKEN id="token-21-0" start_char="2899" end_char="2901">The</TOKEN>
				<TOKEN id="token-21-1" start_char="2903" end_char="2907">first</TOKEN>
				<TOKEN id="token-21-2" start_char="2909" end_char="2916">clinical</TOKEN>
				<TOKEN id="token-21-3" start_char="2918" end_char="2922">trial</TOKEN>
				<TOKEN id="token-21-4" start_char="2924" end_char="2925">of</TOKEN>
				<TOKEN id="token-21-5" start_char="2927" end_char="2936">remdesivir</TOKEN>
				<TOKEN id="token-21-6" start_char="2938" end_char="2939">on</TOKEN>
				<TOKEN id="token-21-7" start_char="2941" end_char="2945">COVID</TOKEN>
				<TOKEN id="token-21-8" start_char="2946" end_char="2946">-</TOKEN>
				<TOKEN id="token-21-9" start_char="2947" end_char="2948">19</TOKEN>
				<TOKEN id="token-21-10" start_char="2950" end_char="2957">patients</TOKEN>
				<TOKEN id="token-21-11" start_char="2959" end_char="2960">in</TOKEN>
				<TOKEN id="token-21-12" start_char="2962" end_char="2968">serious</TOKEN>
				<TOKEN id="token-21-13" start_char="2970" end_char="2978">condition</TOKEN>
				<TOKEN id="token-21-14" start_char="2980" end_char="2982">was</TOKEN>
				<TOKEN id="token-21-15" start_char="2984" end_char="2992">conducted</TOKEN>
				<TOKEN id="token-21-16" start_char="2994" end_char="2995">by</TOKEN>
				<TOKEN id="token-21-17" start_char="2997" end_char="2999">the</TOKEN>
				<TOKEN id="token-21-18" start_char="3001" end_char="3010">University</TOKEN>
				<TOKEN id="token-21-19" start_char="3012" end_char="3013">of</TOKEN>
				<TOKEN id="token-21-20" start_char="3015" end_char="3021">Chicago</TOKEN>
				<TOKEN id="token-21-21" start_char="3023" end_char="3030">Medicine</TOKEN>
				<TOKEN id="token-21-22" start_char="3032" end_char="3034">and</TOKEN>
				<TOKEN id="token-21-23" start_char="3036" end_char="3043">received</TOKEN>
				<TOKEN id="token-21-24" start_char="3045" end_char="3048">some</TOKEN>
				<TOKEN id="token-21-25" start_char="3050" end_char="3057">positive</TOKEN>
				<TOKEN id="token-21-26" start_char="3059" end_char="3065">reviews</TOKEN>
				<TOKEN id="token-21-27" start_char="3066" end_char="3066">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-22" start_char="3068" end_char="3257">
				<ORIGINAL_TEXT>The “clinical trial is seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a week,” the health news website Stat reported on April 16.</ORIGINAL_TEXT>
				<TOKEN id="token-22-0" start_char="3068" end_char="3070">The</TOKEN>
				<TOKEN id="token-22-1" start_char="3072" end_char="3072">“</TOKEN>
				<TOKEN id="token-22-2" start_char="3073" end_char="3080">clinical</TOKEN>
				<TOKEN id="token-22-3" start_char="3082" end_char="3086">trial</TOKEN>
				<TOKEN id="token-22-4" start_char="3088" end_char="3089">is</TOKEN>
				<TOKEN id="token-22-5" start_char="3091" end_char="3096">seeing</TOKEN>
				<TOKEN id="token-22-6" start_char="3098" end_char="3102">rapid</TOKEN>
				<TOKEN id="token-22-7" start_char="3104" end_char="3113">recoveries</TOKEN>
				<TOKEN id="token-22-8" start_char="3115" end_char="3116">in</TOKEN>
				<TOKEN id="token-22-9" start_char="3118" end_char="3122">fever</TOKEN>
				<TOKEN id="token-22-10" start_char="3124" end_char="3126">and</TOKEN>
				<TOKEN id="token-22-11" start_char="3128" end_char="3138">respiratory</TOKEN>
				<TOKEN id="token-22-12" start_char="3140" end_char="3147">symptoms</TOKEN>
				<TOKEN id="token-22-13" start_char="3148" end_char="3148">,</TOKEN>
				<TOKEN id="token-22-14" start_char="3150" end_char="3153">with</TOKEN>
				<TOKEN id="token-22-15" start_char="3155" end_char="3160">nearly</TOKEN>
				<TOKEN id="token-22-16" start_char="3162" end_char="3164">all</TOKEN>
				<TOKEN id="token-22-17" start_char="3166" end_char="3173">patients</TOKEN>
				<TOKEN id="token-22-18" start_char="3175" end_char="3184">discharged</TOKEN>
				<TOKEN id="token-22-19" start_char="3186" end_char="3187">in</TOKEN>
				<TOKEN id="token-22-20" start_char="3189" end_char="3192">less</TOKEN>
				<TOKEN id="token-22-21" start_char="3194" end_char="3197">than</TOKEN>
				<TOKEN id="token-22-22" start_char="3199" end_char="3199">a</TOKEN>
				<TOKEN id="token-22-23" start_char="3201" end_char="3204">week</TOKEN>
				<TOKEN id="token-22-24" start_char="3205" end_char="3206">,”</TOKEN>
				<TOKEN id="token-22-25" start_char="3208" end_char="3210">the</TOKEN>
				<TOKEN id="token-22-26" start_char="3212" end_char="3217">health</TOKEN>
				<TOKEN id="token-22-27" start_char="3219" end_char="3222">news</TOKEN>
				<TOKEN id="token-22-28" start_char="3224" end_char="3230">website</TOKEN>
				<TOKEN id="token-22-29" start_char="3232" end_char="3235">Stat</TOKEN>
				<TOKEN id="token-22-30" start_char="3237" end_char="3244">reported</TOKEN>
				<TOKEN id="token-22-31" start_char="3246" end_char="3247">on</TOKEN>
				<TOKEN id="token-22-32" start_char="3249" end_char="3253">April</TOKEN>
				<TOKEN id="token-22-33" start_char="3255" end_char="3256">16</TOKEN>
				<TOKEN id="token-22-34" start_char="3257" end_char="3257">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-23" start_char="3259" end_char="3392">
				<ORIGINAL_TEXT>News Front Georgia also ignored the fact that Gilead Sciences swiftly responded to the Financial Times report about the Chinese trial.</ORIGINAL_TEXT>
				<TOKEN id="token-23-0" start_char="3259" end_char="3262">News</TOKEN>
				<TOKEN id="token-23-1" start_char="3264" end_char="3268">Front</TOKEN>
				<TOKEN id="token-23-2" start_char="3270" end_char="3276">Georgia</TOKEN>
				<TOKEN id="token-23-3" start_char="3278" end_char="3281">also</TOKEN>
				<TOKEN id="token-23-4" start_char="3283" end_char="3289">ignored</TOKEN>
				<TOKEN id="token-23-5" start_char="3291" end_char="3293">the</TOKEN>
				<TOKEN id="token-23-6" start_char="3295" end_char="3298">fact</TOKEN>
				<TOKEN id="token-23-7" start_char="3300" end_char="3303">that</TOKEN>
				<TOKEN id="token-23-8" start_char="3305" end_char="3310">Gilead</TOKEN>
				<TOKEN id="token-23-9" start_char="3312" end_char="3319">Sciences</TOKEN>
				<TOKEN id="token-23-10" start_char="3321" end_char="3327">swiftly</TOKEN>
				<TOKEN id="token-23-11" start_char="3329" end_char="3337">responded</TOKEN>
				<TOKEN id="token-23-12" start_char="3339" end_char="3340">to</TOKEN>
				<TOKEN id="token-23-13" start_char="3342" end_char="3344">the</TOKEN>
				<TOKEN id="token-23-14" start_char="3346" end_char="3354">Financial</TOKEN>
				<TOKEN id="token-23-15" start_char="3356" end_char="3360">Times</TOKEN>
				<TOKEN id="token-23-16" start_char="3362" end_char="3367">report</TOKEN>
				<TOKEN id="token-23-17" start_char="3369" end_char="3373">about</TOKEN>
				<TOKEN id="token-23-18" start_char="3375" end_char="3377">the</TOKEN>
				<TOKEN id="token-23-19" start_char="3379" end_char="3385">Chinese</TOKEN>
				<TOKEN id="token-23-20" start_char="3387" end_char="3391">trial</TOKEN>
				<TOKEN id="token-23-21" start_char="3392" end_char="3392">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-24" start_char="3394" end_char="3612">
				<ORIGINAL_TEXT>The company said a summary of the results of the trial was published by the WHO prematurely, without the consent of the researchers who conducted it, and that it contained “inappropriate characterizations of the study.”</ORIGINAL_TEXT>
				<TOKEN id="token-24-0" start_char="3394" end_char="3396">The</TOKEN>
				<TOKEN id="token-24-1" start_char="3398" end_char="3404">company</TOKEN>
				<TOKEN id="token-24-2" start_char="3406" end_char="3409">said</TOKEN>
				<TOKEN id="token-24-3" start_char="3411" end_char="3411">a</TOKEN>
				<TOKEN id="token-24-4" start_char="3413" end_char="3419">summary</TOKEN>
				<TOKEN id="token-24-5" start_char="3421" end_char="3422">of</TOKEN>
				<TOKEN id="token-24-6" start_char="3424" end_char="3426">the</TOKEN>
				<TOKEN id="token-24-7" start_char="3428" end_char="3434">results</TOKEN>
				<TOKEN id="token-24-8" start_char="3436" end_char="3437">of</TOKEN>
				<TOKEN id="token-24-9" start_char="3439" end_char="3441">the</TOKEN>
				<TOKEN id="token-24-10" start_char="3443" end_char="3447">trial</TOKEN>
				<TOKEN id="token-24-11" start_char="3449" end_char="3451">was</TOKEN>
				<TOKEN id="token-24-12" start_char="3453" end_char="3461">published</TOKEN>
				<TOKEN id="token-24-13" start_char="3463" end_char="3464">by</TOKEN>
				<TOKEN id="token-24-14" start_char="3466" end_char="3468">the</TOKEN>
				<TOKEN id="token-24-15" start_char="3470" end_char="3472">WHO</TOKEN>
				<TOKEN id="token-24-16" start_char="3474" end_char="3484">prematurely</TOKEN>
				<TOKEN id="token-24-17" start_char="3485" end_char="3485">,</TOKEN>
				<TOKEN id="token-24-18" start_char="3487" end_char="3493">without</TOKEN>
				<TOKEN id="token-24-19" start_char="3495" end_char="3497">the</TOKEN>
				<TOKEN id="token-24-20" start_char="3499" end_char="3505">consent</TOKEN>
				<TOKEN id="token-24-21" start_char="3507" end_char="3508">of</TOKEN>
				<TOKEN id="token-24-22" start_char="3510" end_char="3512">the</TOKEN>
				<TOKEN id="token-24-23" start_char="3514" end_char="3524">researchers</TOKEN>
				<TOKEN id="token-24-24" start_char="3526" end_char="3528">who</TOKEN>
				<TOKEN id="token-24-25" start_char="3530" end_char="3538">conducted</TOKEN>
				<TOKEN id="token-24-26" start_char="3540" end_char="3541">it</TOKEN>
				<TOKEN id="token-24-27" start_char="3542" end_char="3542">,</TOKEN>
				<TOKEN id="token-24-28" start_char="3544" end_char="3546">and</TOKEN>
				<TOKEN id="token-24-29" start_char="3548" end_char="3551">that</TOKEN>
				<TOKEN id="token-24-30" start_char="3553" end_char="3554">it</TOKEN>
				<TOKEN id="token-24-31" start_char="3556" end_char="3564">contained</TOKEN>
				<TOKEN id="token-24-32" start_char="3566" end_char="3566">“</TOKEN>
				<TOKEN id="token-24-33" start_char="3567" end_char="3579">inappropriate</TOKEN>
				<TOKEN id="token-24-34" start_char="3581" end_char="3597">characterizations</TOKEN>
				<TOKEN id="token-24-35" start_char="3599" end_char="3600">of</TOKEN>
				<TOKEN id="token-24-36" start_char="3602" end_char="3604">the</TOKEN>
				<TOKEN id="token-24-37" start_char="3606" end_char="3610">study</TOKEN>
				<TOKEN id="token-24-38" start_char="3611" end_char="3612">.”</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-25" start_char="3614" end_char="3817">
				<ORIGINAL_TEXT>According to STAT, the WHO removed the summary from its website and issued a statement saying that the document “was inadvertently posted on the website and taken down as soon as the mistake was noticed.”</ORIGINAL_TEXT>
				<TOKEN id="token-25-0" start_char="3614" end_char="3622">According</TOKEN>
				<TOKEN id="token-25-1" start_char="3624" end_char="3625">to</TOKEN>
				<TOKEN id="token-25-2" start_char="3627" end_char="3630">STAT</TOKEN>
				<TOKEN id="token-25-3" start_char="3631" end_char="3631">,</TOKEN>
				<TOKEN id="token-25-4" start_char="3633" end_char="3635">the</TOKEN>
				<TOKEN id="token-25-5" start_char="3637" end_char="3639">WHO</TOKEN>
				<TOKEN id="token-25-6" start_char="3641" end_char="3647">removed</TOKEN>
				<TOKEN id="token-25-7" start_char="3649" end_char="3651">the</TOKEN>
				<TOKEN id="token-25-8" start_char="3653" end_char="3659">summary</TOKEN>
				<TOKEN id="token-25-9" start_char="3661" end_char="3664">from</TOKEN>
				<TOKEN id="token-25-10" start_char="3666" end_char="3668">its</TOKEN>
				<TOKEN id="token-25-11" start_char="3670" end_char="3676">website</TOKEN>
				<TOKEN id="token-25-12" start_char="3678" end_char="3680">and</TOKEN>
				<TOKEN id="token-25-13" start_char="3682" end_char="3687">issued</TOKEN>
				<TOKEN id="token-25-14" start_char="3689" end_char="3689">a</TOKEN>
				<TOKEN id="token-25-15" start_char="3691" end_char="3699">statement</TOKEN>
				<TOKEN id="token-25-16" start_char="3701" end_char="3706">saying</TOKEN>
				<TOKEN id="token-25-17" start_char="3708" end_char="3711">that</TOKEN>
				<TOKEN id="token-25-18" start_char="3713" end_char="3715">the</TOKEN>
				<TOKEN id="token-25-19" start_char="3717" end_char="3724">document</TOKEN>
				<TOKEN id="token-25-20" start_char="3726" end_char="3726">“</TOKEN>
				<TOKEN id="token-25-21" start_char="3727" end_char="3729">was</TOKEN>
				<TOKEN id="token-25-22" start_char="3731" end_char="3743">inadvertently</TOKEN>
				<TOKEN id="token-25-23" start_char="3745" end_char="3750">posted</TOKEN>
				<TOKEN id="token-25-24" start_char="3752" end_char="3753">on</TOKEN>
				<TOKEN id="token-25-25" start_char="3755" end_char="3757">the</TOKEN>
				<TOKEN id="token-25-26" start_char="3759" end_char="3765">website</TOKEN>
				<TOKEN id="token-25-27" start_char="3767" end_char="3769">and</TOKEN>
				<TOKEN id="token-25-28" start_char="3771" end_char="3775">taken</TOKEN>
				<TOKEN id="token-25-29" start_char="3777" end_char="3780">down</TOKEN>
				<TOKEN id="token-25-30" start_char="3782" end_char="3783">as</TOKEN>
				<TOKEN id="token-25-31" start_char="3785" end_char="3788">soon</TOKEN>
				<TOKEN id="token-25-32" start_char="3790" end_char="3791">as</TOKEN>
				<TOKEN id="token-25-33" start_char="3793" end_char="3795">the</TOKEN>
				<TOKEN id="token-25-34" start_char="3797" end_char="3803">mistake</TOKEN>
				<TOKEN id="token-25-35" start_char="3805" end_char="3807">was</TOKEN>
				<TOKEN id="token-25-36" start_char="3809" end_char="3815">noticed</TOKEN>
				<TOKEN id="token-25-37" start_char="3816" end_char="3817">.”</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-26" start_char="3819" end_char="3964">
				<ORIGINAL_TEXT>According to the News Front Georgia story, a total of 237 patients were involved in the clinical trial, of which 158 were treated with remdesivir.</ORIGINAL_TEXT>
				<TOKEN id="token-26-0" start_char="3819" end_char="3827">According</TOKEN>
				<TOKEN id="token-26-1" start_char="3829" end_char="3830">to</TOKEN>
				<TOKEN id="token-26-2" start_char="3832" end_char="3834">the</TOKEN>
				<TOKEN id="token-26-3" start_char="3836" end_char="3839">News</TOKEN>
				<TOKEN id="token-26-4" start_char="3841" end_char="3845">Front</TOKEN>
				<TOKEN id="token-26-5" start_char="3847" end_char="3853">Georgia</TOKEN>
				<TOKEN id="token-26-6" start_char="3855" end_char="3859">story</TOKEN>
				<TOKEN id="token-26-7" start_char="3860" end_char="3860">,</TOKEN>
				<TOKEN id="token-26-8" start_char="3862" end_char="3862">a</TOKEN>
				<TOKEN id="token-26-9" start_char="3864" end_char="3868">total</TOKEN>
				<TOKEN id="token-26-10" start_char="3870" end_char="3871">of</TOKEN>
				<TOKEN id="token-26-11" start_char="3873" end_char="3875">237</TOKEN>
				<TOKEN id="token-26-12" start_char="3877" end_char="3884">patients</TOKEN>
				<TOKEN id="token-26-13" start_char="3886" end_char="3889">were</TOKEN>
				<TOKEN id="token-26-14" start_char="3891" end_char="3898">involved</TOKEN>
				<TOKEN id="token-26-15" start_char="3900" end_char="3901">in</TOKEN>
				<TOKEN id="token-26-16" start_char="3903" end_char="3905">the</TOKEN>
				<TOKEN id="token-26-17" start_char="3907" end_char="3914">clinical</TOKEN>
				<TOKEN id="token-26-18" start_char="3916" end_char="3920">trial</TOKEN>
				<TOKEN id="token-26-19" start_char="3921" end_char="3921">,</TOKEN>
				<TOKEN id="token-26-20" start_char="3923" end_char="3924">of</TOKEN>
				<TOKEN id="token-26-21" start_char="3926" end_char="3930">which</TOKEN>
				<TOKEN id="token-26-22" start_char="3932" end_char="3934">158</TOKEN>
				<TOKEN id="token-26-23" start_char="3936" end_char="3939">were</TOKEN>
				<TOKEN id="token-26-24" start_char="3941" end_char="3947">treated</TOKEN>
				<TOKEN id="token-26-25" start_char="3949" end_char="3952">with</TOKEN>
				<TOKEN id="token-26-26" start_char="3954" end_char="3963">remdesivir</TOKEN>
				<TOKEN id="token-26-27" start_char="3964" end_char="3964">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-27" start_char="3966" end_char="4093">
				<ORIGINAL_TEXT>None of these patients showed improvement, and 18 patients dropped out of the study because of significant adverse side effects.</ORIGINAL_TEXT>
				<TOKEN id="token-27-0" start_char="3966" end_char="3969">None</TOKEN>
				<TOKEN id="token-27-1" start_char="3971" end_char="3972">of</TOKEN>
				<TOKEN id="token-27-2" start_char="3974" end_char="3978">these</TOKEN>
				<TOKEN id="token-27-3" start_char="3980" end_char="3987">patients</TOKEN>
				<TOKEN id="token-27-4" start_char="3989" end_char="3994">showed</TOKEN>
				<TOKEN id="token-27-5" start_char="3996" end_char="4006">improvement</TOKEN>
				<TOKEN id="token-27-6" start_char="4007" end_char="4007">,</TOKEN>
				<TOKEN id="token-27-7" start_char="4009" end_char="4011">and</TOKEN>
				<TOKEN id="token-27-8" start_char="4013" end_char="4014">18</TOKEN>
				<TOKEN id="token-27-9" start_char="4016" end_char="4023">patients</TOKEN>
				<TOKEN id="token-27-10" start_char="4025" end_char="4031">dropped</TOKEN>
				<TOKEN id="token-27-11" start_char="4033" end_char="4035">out</TOKEN>
				<TOKEN id="token-27-12" start_char="4037" end_char="4038">of</TOKEN>
				<TOKEN id="token-27-13" start_char="4040" end_char="4042">the</TOKEN>
				<TOKEN id="token-27-14" start_char="4044" end_char="4048">study</TOKEN>
				<TOKEN id="token-27-15" start_char="4050" end_char="4056">because</TOKEN>
				<TOKEN id="token-27-16" start_char="4058" end_char="4059">of</TOKEN>
				<TOKEN id="token-27-17" start_char="4061" end_char="4071">significant</TOKEN>
				<TOKEN id="token-27-18" start_char="4073" end_char="4079">adverse</TOKEN>
				<TOKEN id="token-27-19" start_char="4081" end_char="4084">side</TOKEN>
				<TOKEN id="token-27-20" start_char="4086" end_char="4092">effects</TOKEN>
				<TOKEN id="token-27-21" start_char="4093" end_char="4093">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-28" start_char="4095" end_char="4315">
				<ORIGINAL_TEXT>Although the numbers correspond with the data in the WHO document, a snapshot of which was published by STAT, News Front failed to report that the study was terminated prematurely or the reasons for the early termination.</ORIGINAL_TEXT>
				<TOKEN id="token-28-0" start_char="4095" end_char="4102">Although</TOKEN>
				<TOKEN id="token-28-1" start_char="4104" end_char="4106">the</TOKEN>
				<TOKEN id="token-28-2" start_char="4108" end_char="4114">numbers</TOKEN>
				<TOKEN id="token-28-3" start_char="4116" end_char="4125">correspond</TOKEN>
				<TOKEN id="token-28-4" start_char="4127" end_char="4130">with</TOKEN>
				<TOKEN id="token-28-5" start_char="4132" end_char="4134">the</TOKEN>
				<TOKEN id="token-28-6" start_char="4136" end_char="4139">data</TOKEN>
				<TOKEN id="token-28-7" start_char="4141" end_char="4142">in</TOKEN>
				<TOKEN id="token-28-8" start_char="4144" end_char="4146">the</TOKEN>
				<TOKEN id="token-28-9" start_char="4148" end_char="4150">WHO</TOKEN>
				<TOKEN id="token-28-10" start_char="4152" end_char="4159">document</TOKEN>
				<TOKEN id="token-28-11" start_char="4160" end_char="4160">,</TOKEN>
				<TOKEN id="token-28-12" start_char="4162" end_char="4162">a</TOKEN>
				<TOKEN id="token-28-13" start_char="4164" end_char="4171">snapshot</TOKEN>
				<TOKEN id="token-28-14" start_char="4173" end_char="4174">of</TOKEN>
				<TOKEN id="token-28-15" start_char="4176" end_char="4180">which</TOKEN>
				<TOKEN id="token-28-16" start_char="4182" end_char="4184">was</TOKEN>
				<TOKEN id="token-28-17" start_char="4186" end_char="4194">published</TOKEN>
				<TOKEN id="token-28-18" start_char="4196" end_char="4197">by</TOKEN>
				<TOKEN id="token-28-19" start_char="4199" end_char="4202">STAT</TOKEN>
				<TOKEN id="token-28-20" start_char="4203" end_char="4203">,</TOKEN>
				<TOKEN id="token-28-21" start_char="4205" end_char="4208">News</TOKEN>
				<TOKEN id="token-28-22" start_char="4210" end_char="4214">Front</TOKEN>
				<TOKEN id="token-28-23" start_char="4216" end_char="4221">failed</TOKEN>
				<TOKEN id="token-28-24" start_char="4223" end_char="4224">to</TOKEN>
				<TOKEN id="token-28-25" start_char="4226" end_char="4231">report</TOKEN>
				<TOKEN id="token-28-26" start_char="4233" end_char="4236">that</TOKEN>
				<TOKEN id="token-28-27" start_char="4238" end_char="4240">the</TOKEN>
				<TOKEN id="token-28-28" start_char="4242" end_char="4246">study</TOKEN>
				<TOKEN id="token-28-29" start_char="4248" end_char="4250">was</TOKEN>
				<TOKEN id="token-28-30" start_char="4252" end_char="4261">terminated</TOKEN>
				<TOKEN id="token-28-31" start_char="4263" end_char="4273">prematurely</TOKEN>
				<TOKEN id="token-28-32" start_char="4275" end_char="4276">or</TOKEN>
				<TOKEN id="token-28-33" start_char="4278" end_char="4280">the</TOKEN>
				<TOKEN id="token-28-34" start_char="4282" end_char="4288">reasons</TOKEN>
				<TOKEN id="token-28-35" start_char="4290" end_char="4292">for</TOKEN>
				<TOKEN id="token-28-36" start_char="4294" end_char="4296">the</TOKEN>
				<TOKEN id="token-28-37" start_char="4298" end_char="4302">early</TOKEN>
				<TOKEN id="token-28-38" start_char="4304" end_char="4314">termination</TOKEN>
				<TOKEN id="token-28-39" start_char="4315" end_char="4315">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-29" start_char="4317" end_char="4458">
				<ORIGINAL_TEXT>Gilead Sciences said it was shut down because a low number of participants was insufficient to provide “statistically meaningful conclusions.”</ORIGINAL_TEXT>
				<TOKEN id="token-29-0" start_char="4317" end_char="4322">Gilead</TOKEN>
				<TOKEN id="token-29-1" start_char="4324" end_char="4331">Sciences</TOKEN>
				<TOKEN id="token-29-2" start_char="4333" end_char="4336">said</TOKEN>
				<TOKEN id="token-29-3" start_char="4338" end_char="4339">it</TOKEN>
				<TOKEN id="token-29-4" start_char="4341" end_char="4343">was</TOKEN>
				<TOKEN id="token-29-5" start_char="4345" end_char="4348">shut</TOKEN>
				<TOKEN id="token-29-6" start_char="4350" end_char="4353">down</TOKEN>
				<TOKEN id="token-29-7" start_char="4355" end_char="4361">because</TOKEN>
				<TOKEN id="token-29-8" start_char="4363" end_char="4363">a</TOKEN>
				<TOKEN id="token-29-9" start_char="4365" end_char="4367">low</TOKEN>
				<TOKEN id="token-29-10" start_char="4369" end_char="4374">number</TOKEN>
				<TOKEN id="token-29-11" start_char="4376" end_char="4377">of</TOKEN>
				<TOKEN id="token-29-12" start_char="4379" end_char="4390">participants</TOKEN>
				<TOKEN id="token-29-13" start_char="4392" end_char="4394">was</TOKEN>
				<TOKEN id="token-29-14" start_char="4396" end_char="4407">insufficient</TOKEN>
				<TOKEN id="token-29-15" start_char="4409" end_char="4410">to</TOKEN>
				<TOKEN id="token-29-16" start_char="4412" end_char="4418">provide</TOKEN>
				<TOKEN id="token-29-17" start_char="4420" end_char="4420">“</TOKEN>
				<TOKEN id="token-29-18" start_char="4421" end_char="4433">statistically</TOKEN>
				<TOKEN id="token-29-19" start_char="4435" end_char="4444">meaningful</TOKEN>
				<TOKEN id="token-29-20" start_char="4446" end_char="4456">conclusions</TOKEN>
				<TOKEN id="token-29-21" start_char="4457" end_char="4458">.”</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-30" start_char="4460" end_char="4658">
				<ORIGINAL_TEXT>There should have been 453 patients in the trial, but China failed to enroll that many because the epidemic had been “controlled well” in the country, according to China’s Capital Medical University.</ORIGINAL_TEXT>
				<TOKEN id="token-30-0" start_char="4460" end_char="4464">There</TOKEN>
				<TOKEN id="token-30-1" start_char="4466" end_char="4471">should</TOKEN>
				<TOKEN id="token-30-2" start_char="4473" end_char="4476">have</TOKEN>
				<TOKEN id="token-30-3" start_char="4478" end_char="4481">been</TOKEN>
				<TOKEN id="token-30-4" start_char="4483" end_char="4485">453</TOKEN>
				<TOKEN id="token-30-5" start_char="4487" end_char="4494">patients</TOKEN>
				<TOKEN id="token-30-6" start_char="4496" end_char="4497">in</TOKEN>
				<TOKEN id="token-30-7" start_char="4499" end_char="4501">the</TOKEN>
				<TOKEN id="token-30-8" start_char="4503" end_char="4507">trial</TOKEN>
				<TOKEN id="token-30-9" start_char="4508" end_char="4508">,</TOKEN>
				<TOKEN id="token-30-10" start_char="4510" end_char="4512">but</TOKEN>
				<TOKEN id="token-30-11" start_char="4514" end_char="4518">China</TOKEN>
				<TOKEN id="token-30-12" start_char="4520" end_char="4525">failed</TOKEN>
				<TOKEN id="token-30-13" start_char="4527" end_char="4528">to</TOKEN>
				<TOKEN id="token-30-14" start_char="4530" end_char="4535">enroll</TOKEN>
				<TOKEN id="token-30-15" start_char="4537" end_char="4540">that</TOKEN>
				<TOKEN id="token-30-16" start_char="4542" end_char="4545">many</TOKEN>
				<TOKEN id="token-30-17" start_char="4547" end_char="4553">because</TOKEN>
				<TOKEN id="token-30-18" start_char="4555" end_char="4557">the</TOKEN>
				<TOKEN id="token-30-19" start_char="4559" end_char="4566">epidemic</TOKEN>
				<TOKEN id="token-30-20" start_char="4568" end_char="4570">had</TOKEN>
				<TOKEN id="token-30-21" start_char="4572" end_char="4575">been</TOKEN>
				<TOKEN id="token-30-22" start_char="4577" end_char="4577">“</TOKEN>
				<TOKEN id="token-30-23" start_char="4578" end_char="4587">controlled</TOKEN>
				<TOKEN id="token-30-24" start_char="4589" end_char="4592">well</TOKEN>
				<TOKEN id="token-30-25" start_char="4593" end_char="4593">”</TOKEN>
				<TOKEN id="token-30-26" start_char="4595" end_char="4596">in</TOKEN>
				<TOKEN id="token-30-27" start_char="4598" end_char="4600">the</TOKEN>
				<TOKEN id="token-30-28" start_char="4602" end_char="4608">country</TOKEN>
				<TOKEN id="token-30-29" start_char="4609" end_char="4609">,</TOKEN>
				<TOKEN id="token-30-30" start_char="4611" end_char="4619">according</TOKEN>
				<TOKEN id="token-30-31" start_char="4621" end_char="4622">to</TOKEN>
				<TOKEN id="token-30-32" start_char="4624" end_char="4628">China</TOKEN>
				<TOKEN id="token-30-33" start_char="4629" end_char="4629">’</TOKEN>
				<TOKEN id="token-30-34" start_char="4630" end_char="4630">s</TOKEN>
				<TOKEN id="token-30-35" start_char="4632" end_char="4638">Capital</TOKEN>
				<TOKEN id="token-30-36" start_char="4640" end_char="4646">Medical</TOKEN>
				<TOKEN id="token-30-37" start_char="4648" end_char="4657">University</TOKEN>
				<TOKEN id="token-30-38" start_char="4658" end_char="4658">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-31" start_char="4660" end_char="4962">
				<ORIGINAL_TEXT>News Front Georgia also erroneously reported that Gilead Sciences is co-owned by former U.S. Defense Secretary Donald Rumsfeld and claimed that the company had supplied the Lugar Lab in Tbilisi, Georgia, with the company’s hepatitis C medication, Sovaldi, so that it could be tried on Georgian citizens.</ORIGINAL_TEXT>
				<TOKEN id="token-31-0" start_char="4660" end_char="4663">News</TOKEN>
				<TOKEN id="token-31-1" start_char="4665" end_char="4669">Front</TOKEN>
				<TOKEN id="token-31-2" start_char="4671" end_char="4677">Georgia</TOKEN>
				<TOKEN id="token-31-3" start_char="4679" end_char="4682">also</TOKEN>
				<TOKEN id="token-31-4" start_char="4684" end_char="4694">erroneously</TOKEN>
				<TOKEN id="token-31-5" start_char="4696" end_char="4703">reported</TOKEN>
				<TOKEN id="token-31-6" start_char="4705" end_char="4708">that</TOKEN>
				<TOKEN id="token-31-7" start_char="4710" end_char="4715">Gilead</TOKEN>
				<TOKEN id="token-31-8" start_char="4717" end_char="4724">Sciences</TOKEN>
				<TOKEN id="token-31-9" start_char="4726" end_char="4727">is</TOKEN>
				<TOKEN id="token-31-10" start_char="4729" end_char="4730">co</TOKEN>
				<TOKEN id="token-31-11" start_char="4731" end_char="4731">-</TOKEN>
				<TOKEN id="token-31-12" start_char="4732" end_char="4736">owned</TOKEN>
				<TOKEN id="token-31-13" start_char="4738" end_char="4739">by</TOKEN>
				<TOKEN id="token-31-14" start_char="4741" end_char="4746">former</TOKEN>
				<TOKEN id="token-31-15" start_char="4748" end_char="4748">U</TOKEN>
				<TOKEN id="token-31-16" start_char="4749" end_char="4749">.</TOKEN>
				<TOKEN id="token-31-17" start_char="4750" end_char="4750">S</TOKEN>
				<TOKEN id="token-31-18" start_char="4751" end_char="4751">.</TOKEN>
				<TOKEN id="token-31-19" start_char="4753" end_char="4759">Defense</TOKEN>
				<TOKEN id="token-31-20" start_char="4761" end_char="4769">Secretary</TOKEN>
				<TOKEN id="token-31-21" start_char="4771" end_char="4776">Donald</TOKEN>
				<TOKEN id="token-31-22" start_char="4778" end_char="4785">Rumsfeld</TOKEN>
				<TOKEN id="token-31-23" start_char="4787" end_char="4789">and</TOKEN>
				<TOKEN id="token-31-24" start_char="4791" end_char="4797">claimed</TOKEN>
				<TOKEN id="token-31-25" start_char="4799" end_char="4802">that</TOKEN>
				<TOKEN id="token-31-26" start_char="4804" end_char="4806">the</TOKEN>
				<TOKEN id="token-31-27" start_char="4808" end_char="4814">company</TOKEN>
				<TOKEN id="token-31-28" start_char="4816" end_char="4818">had</TOKEN>
				<TOKEN id="token-31-29" start_char="4820" end_char="4827">supplied</TOKEN>
				<TOKEN id="token-31-30" start_char="4829" end_char="4831">the</TOKEN>
				<TOKEN id="token-31-31" start_char="4833" end_char="4837">Lugar</TOKEN>
				<TOKEN id="token-31-32" start_char="4839" end_char="4841">Lab</TOKEN>
				<TOKEN id="token-31-33" start_char="4843" end_char="4844">in</TOKEN>
				<TOKEN id="token-31-34" start_char="4846" end_char="4852">Tbilisi</TOKEN>
				<TOKEN id="token-31-35" start_char="4853" end_char="4853">,</TOKEN>
				<TOKEN id="token-31-36" start_char="4855" end_char="4861">Georgia</TOKEN>
				<TOKEN id="token-31-37" start_char="4862" end_char="4862">,</TOKEN>
				<TOKEN id="token-31-38" start_char="4864" end_char="4867">with</TOKEN>
				<TOKEN id="token-31-39" start_char="4869" end_char="4871">the</TOKEN>
				<TOKEN id="token-31-40" start_char="4873" end_char="4879">company</TOKEN>
				<TOKEN id="token-31-41" start_char="4880" end_char="4880">’</TOKEN>
				<TOKEN id="token-31-42" start_char="4881" end_char="4881">s</TOKEN>
				<TOKEN id="token-31-43" start_char="4883" end_char="4891">hepatitis</TOKEN>
				<TOKEN id="token-31-44" start_char="4893" end_char="4893">C</TOKEN>
				<TOKEN id="token-31-45" start_char="4895" end_char="4904">medication</TOKEN>
				<TOKEN id="token-31-46" start_char="4905" end_char="4905">,</TOKEN>
				<TOKEN id="token-31-47" start_char="4907" end_char="4913">Sovaldi</TOKEN>
				<TOKEN id="token-31-48" start_char="4914" end_char="4914">,</TOKEN>
				<TOKEN id="token-31-49" start_char="4916" end_char="4917">so</TOKEN>
				<TOKEN id="token-31-50" start_char="4919" end_char="4922">that</TOKEN>
				<TOKEN id="token-31-51" start_char="4924" end_char="4925">it</TOKEN>
				<TOKEN id="token-31-52" start_char="4927" end_char="4931">could</TOKEN>
				<TOKEN id="token-31-53" start_char="4933" end_char="4934">be</TOKEN>
				<TOKEN id="token-31-54" start_char="4936" end_char="4940">tried</TOKEN>
				<TOKEN id="token-31-55" start_char="4942" end_char="4943">on</TOKEN>
				<TOKEN id="token-31-56" start_char="4945" end_char="4952">Georgian</TOKEN>
				<TOKEN id="token-31-57" start_char="4954" end_char="4961">citizens</TOKEN>
				<TOKEN id="token-31-58" start_char="4962" end_char="4962">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-32" start_char="4964" end_char="5122">
				<ORIGINAL_TEXT>Rumsfeld, who served as defense secretary to U.S. presidents Gerald Ford and George W. Bush, was the chairman of Gilead’s board of directors from 1997 to 2001.</ORIGINAL_TEXT>
				<TOKEN id="token-32-0" start_char="4964" end_char="4971">Rumsfeld</TOKEN>
				<TOKEN id="token-32-1" start_char="4972" end_char="4972">,</TOKEN>
				<TOKEN id="token-32-2" start_char="4974" end_char="4976">who</TOKEN>
				<TOKEN id="token-32-3" start_char="4978" end_char="4983">served</TOKEN>
				<TOKEN id="token-32-4" start_char="4985" end_char="4986">as</TOKEN>
				<TOKEN id="token-32-5" start_char="4988" end_char="4994">defense</TOKEN>
				<TOKEN id="token-32-6" start_char="4996" end_char="5004">secretary</TOKEN>
				<TOKEN id="token-32-7" start_char="5006" end_char="5007">to</TOKEN>
				<TOKEN id="token-32-8" start_char="5009" end_char="5009">U</TOKEN>
				<TOKEN id="token-32-9" start_char="5010" end_char="5010">.</TOKEN>
				<TOKEN id="token-32-10" start_char="5011" end_char="5011">S</TOKEN>
				<TOKEN id="token-32-11" start_char="5012" end_char="5012">.</TOKEN>
				<TOKEN id="token-32-12" start_char="5014" end_char="5023">presidents</TOKEN>
				<TOKEN id="token-32-13" start_char="5025" end_char="5030">Gerald</TOKEN>
				<TOKEN id="token-32-14" start_char="5032" end_char="5035">Ford</TOKEN>
				<TOKEN id="token-32-15" start_char="5037" end_char="5039">and</TOKEN>
				<TOKEN id="token-32-16" start_char="5041" end_char="5046">George</TOKEN>
				<TOKEN id="token-32-17" start_char="5048" end_char="5048">W</TOKEN>
				<TOKEN id="token-32-18" start_char="5049" end_char="5049">.</TOKEN>
				<TOKEN id="token-32-19" start_char="5051" end_char="5054">Bush</TOKEN>
				<TOKEN id="token-32-20" start_char="5055" end_char="5055">,</TOKEN>
				<TOKEN id="token-32-21" start_char="5057" end_char="5059">was</TOKEN>
				<TOKEN id="token-32-22" start_char="5061" end_char="5063">the</TOKEN>
				<TOKEN id="token-32-23" start_char="5065" end_char="5072">chairman</TOKEN>
				<TOKEN id="token-32-24" start_char="5074" end_char="5075">of</TOKEN>
				<TOKEN id="token-32-25" start_char="5077" end_char="5082">Gilead</TOKEN>
				<TOKEN id="token-32-26" start_char="5083" end_char="5083">’</TOKEN>
				<TOKEN id="token-32-27" start_char="5084" end_char="5084">s</TOKEN>
				<TOKEN id="token-32-28" start_char="5086" end_char="5090">board</TOKEN>
				<TOKEN id="token-32-29" start_char="5092" end_char="5093">of</TOKEN>
				<TOKEN id="token-32-30" start_char="5095" end_char="5103">directors</TOKEN>
				<TOKEN id="token-32-31" start_char="5105" end_char="5108">from</TOKEN>
				<TOKEN id="token-32-32" start_char="5110" end_char="5113">1997</TOKEN>
				<TOKEN id="token-32-33" start_char="5115" end_char="5116">to</TOKEN>
				<TOKEN id="token-32-34" start_char="5118" end_char="5121">2001</TOKEN>
				<TOKEN id="token-32-35" start_char="5122" end_char="5122">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-33" start_char="5124" end_char="5179">
				<ORIGINAL_TEXT>He is not listed among Gilead’s top direct shareholders.</ORIGINAL_TEXT>
				<TOKEN id="token-33-0" start_char="5124" end_char="5125">He</TOKEN>
				<TOKEN id="token-33-1" start_char="5127" end_char="5128">is</TOKEN>
				<TOKEN id="token-33-2" start_char="5130" end_char="5132">not</TOKEN>
				<TOKEN id="token-33-3" start_char="5134" end_char="5139">listed</TOKEN>
				<TOKEN id="token-33-4" start_char="5141" end_char="5145">among</TOKEN>
				<TOKEN id="token-33-5" start_char="5147" end_char="5152">Gilead</TOKEN>
				<TOKEN id="token-33-6" start_char="5153" end_char="5153">’</TOKEN>
				<TOKEN id="token-33-7" start_char="5154" end_char="5154">s</TOKEN>
				<TOKEN id="token-33-8" start_char="5156" end_char="5158">top</TOKEN>
				<TOKEN id="token-33-9" start_char="5160" end_char="5165">direct</TOKEN>
				<TOKEN id="token-33-10" start_char="5167" end_char="5178">shareholders</TOKEN>
				<TOKEN id="token-33-11" start_char="5179" end_char="5179">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-34" start_char="5181" end_char="5248">
				<ORIGINAL_TEXT>The largest shareholders in the company are investment institutions.</ORIGINAL_TEXT>
				<TOKEN id="token-34-0" start_char="5181" end_char="5183">The</TOKEN>
				<TOKEN id="token-34-1" start_char="5185" end_char="5191">largest</TOKEN>
				<TOKEN id="token-34-2" start_char="5193" end_char="5204">shareholders</TOKEN>
				<TOKEN id="token-34-3" start_char="5206" end_char="5207">in</TOKEN>
				<TOKEN id="token-34-4" start_char="5209" end_char="5211">the</TOKEN>
				<TOKEN id="token-34-5" start_char="5213" end_char="5219">company</TOKEN>
				<TOKEN id="token-34-6" start_char="5221" end_char="5223">are</TOKEN>
				<TOKEN id="token-34-7" start_char="5225" end_char="5234">investment</TOKEN>
				<TOKEN id="token-34-8" start_char="5236" end_char="5247">institutions</TOKEN>
				<TOKEN id="token-34-9" start_char="5248" end_char="5248">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-35" start_char="5250" end_char="5449">
				<ORIGINAL_TEXT>The News Front Georgia story claimed that experiments using Sovaldi had resulted in the deaths of 49 Georgian citizens, citing documents presented by the former Georgian security chief Igor Giorgadze.</ORIGINAL_TEXT>
				<TOKEN id="token-35-0" start_char="5250" end_char="5252">The</TOKEN>
				<TOKEN id="token-35-1" start_char="5254" end_char="5257">News</TOKEN>
				<TOKEN id="token-35-2" start_char="5259" end_char="5263">Front</TOKEN>
				<TOKEN id="token-35-3" start_char="5265" end_char="5271">Georgia</TOKEN>
				<TOKEN id="token-35-4" start_char="5273" end_char="5277">story</TOKEN>
				<TOKEN id="token-35-5" start_char="5279" end_char="5285">claimed</TOKEN>
				<TOKEN id="token-35-6" start_char="5287" end_char="5290">that</TOKEN>
				<TOKEN id="token-35-7" start_char="5292" end_char="5302">experiments</TOKEN>
				<TOKEN id="token-35-8" start_char="5304" end_char="5308">using</TOKEN>
				<TOKEN id="token-35-9" start_char="5310" end_char="5316">Sovaldi</TOKEN>
				<TOKEN id="token-35-10" start_char="5318" end_char="5320">had</TOKEN>
				<TOKEN id="token-35-11" start_char="5322" end_char="5329">resulted</TOKEN>
				<TOKEN id="token-35-12" start_char="5331" end_char="5332">in</TOKEN>
				<TOKEN id="token-35-13" start_char="5334" end_char="5336">the</TOKEN>
				<TOKEN id="token-35-14" start_char="5338" end_char="5343">deaths</TOKEN>
				<TOKEN id="token-35-15" start_char="5345" end_char="5346">of</TOKEN>
				<TOKEN id="token-35-16" start_char="5348" end_char="5349">49</TOKEN>
				<TOKEN id="token-35-17" start_char="5351" end_char="5358">Georgian</TOKEN>
				<TOKEN id="token-35-18" start_char="5360" end_char="5367">citizens</TOKEN>
				<TOKEN id="token-35-19" start_char="5368" end_char="5368">,</TOKEN>
				<TOKEN id="token-35-20" start_char="5370" end_char="5375">citing</TOKEN>
				<TOKEN id="token-35-21" start_char="5377" end_char="5385">documents</TOKEN>
				<TOKEN id="token-35-22" start_char="5387" end_char="5395">presented</TOKEN>
				<TOKEN id="token-35-23" start_char="5397" end_char="5398">by</TOKEN>
				<TOKEN id="token-35-24" start_char="5400" end_char="5402">the</TOKEN>
				<TOKEN id="token-35-25" start_char="5404" end_char="5409">former</TOKEN>
				<TOKEN id="token-35-26" start_char="5411" end_char="5418">Georgian</TOKEN>
				<TOKEN id="token-35-27" start_char="5420" end_char="5427">security</TOKEN>
				<TOKEN id="token-35-28" start_char="5429" end_char="5433">chief</TOKEN>
				<TOKEN id="token-35-29" start_char="5435" end_char="5438">Igor</TOKEN>
				<TOKEN id="token-35-30" start_char="5440" end_char="5448">Giorgadze</TOKEN>
				<TOKEN id="token-35-31" start_char="5449" end_char="5449">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-36" start_char="5451" end_char="5620">
				<ORIGINAL_TEXT>Giorgadze linked this to the Richard Lugar Center for Public Health Research, a laboratory known as Lugar Lab, which was built jointly by the U.S. and Georgia in Tbilisi.</ORIGINAL_TEXT>
				<TOKEN id="token-36-0" start_char="5451" end_char="5459">Giorgadze</TOKEN>
				<TOKEN id="token-36-1" start_char="5461" end_char="5466">linked</TOKEN>
				<TOKEN id="token-36-2" start_char="5468" end_char="5471">this</TOKEN>
				<TOKEN id="token-36-3" start_char="5473" end_char="5474">to</TOKEN>
				<TOKEN id="token-36-4" start_char="5476" end_char="5478">the</TOKEN>
				<TOKEN id="token-36-5" start_char="5480" end_char="5486">Richard</TOKEN>
				<TOKEN id="token-36-6" start_char="5488" end_char="5492">Lugar</TOKEN>
				<TOKEN id="token-36-7" start_char="5494" end_char="5499">Center</TOKEN>
				<TOKEN id="token-36-8" start_char="5501" end_char="5503">for</TOKEN>
				<TOKEN id="token-36-9" start_char="5505" end_char="5510">Public</TOKEN>
				<TOKEN id="token-36-10" start_char="5512" end_char="5517">Health</TOKEN>
				<TOKEN id="token-36-11" start_char="5519" end_char="5526">Research</TOKEN>
				<TOKEN id="token-36-12" start_char="5527" end_char="5527">,</TOKEN>
				<TOKEN id="token-36-13" start_char="5529" end_char="5529">a</TOKEN>
				<TOKEN id="token-36-14" start_char="5531" end_char="5540">laboratory</TOKEN>
				<TOKEN id="token-36-15" start_char="5542" end_char="5546">known</TOKEN>
				<TOKEN id="token-36-16" start_char="5548" end_char="5549">as</TOKEN>
				<TOKEN id="token-36-17" start_char="5551" end_char="5555">Lugar</TOKEN>
				<TOKEN id="token-36-18" start_char="5557" end_char="5559">Lab</TOKEN>
				<TOKEN id="token-36-19" start_char="5560" end_char="5560">,</TOKEN>
				<TOKEN id="token-36-20" start_char="5562" end_char="5566">which</TOKEN>
				<TOKEN id="token-36-21" start_char="5568" end_char="5570">was</TOKEN>
				<TOKEN id="token-36-22" start_char="5572" end_char="5576">built</TOKEN>
				<TOKEN id="token-36-23" start_char="5578" end_char="5584">jointly</TOKEN>
				<TOKEN id="token-36-24" start_char="5586" end_char="5587">by</TOKEN>
				<TOKEN id="token-36-25" start_char="5589" end_char="5591">the</TOKEN>
				<TOKEN id="token-36-26" start_char="5593" end_char="5593">U</TOKEN>
				<TOKEN id="token-36-27" start_char="5594" end_char="5594">.</TOKEN>
				<TOKEN id="token-36-28" start_char="5595" end_char="5595">S</TOKEN>
				<TOKEN id="token-36-29" start_char="5596" end_char="5596">.</TOKEN>
				<TOKEN id="token-36-30" start_char="5598" end_char="5600">and</TOKEN>
				<TOKEN id="token-36-31" start_char="5602" end_char="5608">Georgia</TOKEN>
				<TOKEN id="token-36-32" start_char="5610" end_char="5611">in</TOKEN>
				<TOKEN id="token-36-33" start_char="5613" end_char="5619">Tbilisi</TOKEN>
				<TOKEN id="token-36-34" start_char="5620" end_char="5620">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-37" start_char="5622" end_char="5709">
				<ORIGINAL_TEXT>Russia has alleged for years that the U.S. develops biological weapons at the Lugar Lab.</ORIGINAL_TEXT>
				<TOKEN id="token-37-0" start_char="5622" end_char="5627">Russia</TOKEN>
				<TOKEN id="token-37-1" start_char="5629" end_char="5631">has</TOKEN>
				<TOKEN id="token-37-2" start_char="5633" end_char="5639">alleged</TOKEN>
				<TOKEN id="token-37-3" start_char="5641" end_char="5643">for</TOKEN>
				<TOKEN id="token-37-4" start_char="5645" end_char="5649">years</TOKEN>
				<TOKEN id="token-37-5" start_char="5651" end_char="5654">that</TOKEN>
				<TOKEN id="token-37-6" start_char="5656" end_char="5658">the</TOKEN>
				<TOKEN id="token-37-7" start_char="5660" end_char="5660">U</TOKEN>
				<TOKEN id="token-37-8" start_char="5661" end_char="5661">.</TOKEN>
				<TOKEN id="token-37-9" start_char="5662" end_char="5662">S</TOKEN>
				<TOKEN id="token-37-10" start_char="5663" end_char="5663">.</TOKEN>
				<TOKEN id="token-37-11" start_char="5665" end_char="5672">develops</TOKEN>
				<TOKEN id="token-37-12" start_char="5674" end_char="5683">biological</TOKEN>
				<TOKEN id="token-37-13" start_char="5685" end_char="5691">weapons</TOKEN>
				<TOKEN id="token-37-14" start_char="5693" end_char="5694">at</TOKEN>
				<TOKEN id="token-37-15" start_char="5696" end_char="5698">the</TOKEN>
				<TOKEN id="token-37-16" start_char="5700" end_char="5704">Lugar</TOKEN>
				<TOKEN id="token-37-17" start_char="5706" end_char="5708">Lab</TOKEN>
				<TOKEN id="token-37-18" start_char="5709" end_char="5709">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-38" start_char="5711" end_char="5779">
				<ORIGINAL_TEXT>These recycled claims have been previously examined and proven false.</ORIGINAL_TEXT>
				<TOKEN id="token-38-0" start_char="5711" end_char="5715">These</TOKEN>
				<TOKEN id="token-38-1" start_char="5717" end_char="5724">recycled</TOKEN>
				<TOKEN id="token-38-2" start_char="5726" end_char="5731">claims</TOKEN>
				<TOKEN id="token-38-3" start_char="5733" end_char="5736">have</TOKEN>
				<TOKEN id="token-38-4" start_char="5738" end_char="5741">been</TOKEN>
				<TOKEN id="token-38-5" start_char="5743" end_char="5752">previously</TOKEN>
				<TOKEN id="token-38-6" start_char="5754" end_char="5761">examined</TOKEN>
				<TOKEN id="token-38-7" start_char="5763" end_char="5765">and</TOKEN>
				<TOKEN id="token-38-8" start_char="5767" end_char="5772">proven</TOKEN>
				<TOKEN id="token-38-9" start_char="5774" end_char="5778">false</TOKEN>
				<TOKEN id="token-38-10" start_char="5779" end_char="5779">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-39" start_char="5781" end_char="5884">
				<ORIGINAL_TEXT>Sovaldi was approved by the FDA in 2013, and a hepatitis C elimination program began in Georgia in 2015.</ORIGINAL_TEXT>
				<TOKEN id="token-39-0" start_char="5781" end_char="5787">Sovaldi</TOKEN>
				<TOKEN id="token-39-1" start_char="5789" end_char="5791">was</TOKEN>
				<TOKEN id="token-39-2" start_char="5793" end_char="5800">approved</TOKEN>
				<TOKEN id="token-39-3" start_char="5802" end_char="5803">by</TOKEN>
				<TOKEN id="token-39-4" start_char="5805" end_char="5807">the</TOKEN>
				<TOKEN id="token-39-5" start_char="5809" end_char="5811">FDA</TOKEN>
				<TOKEN id="token-39-6" start_char="5813" end_char="5814">in</TOKEN>
				<TOKEN id="token-39-7" start_char="5816" end_char="5819">2013</TOKEN>
				<TOKEN id="token-39-8" start_char="5820" end_char="5820">,</TOKEN>
				<TOKEN id="token-39-9" start_char="5822" end_char="5824">and</TOKEN>
				<TOKEN id="token-39-10" start_char="5826" end_char="5826">a</TOKEN>
				<TOKEN id="token-39-11" start_char="5828" end_char="5836">hepatitis</TOKEN>
				<TOKEN id="token-39-12" start_char="5838" end_char="5838">C</TOKEN>
				<TOKEN id="token-39-13" start_char="5840" end_char="5850">elimination</TOKEN>
				<TOKEN id="token-39-14" start_char="5852" end_char="5858">program</TOKEN>
				<TOKEN id="token-39-15" start_char="5860" end_char="5864">began</TOKEN>
				<TOKEN id="token-39-16" start_char="5866" end_char="5867">in</TOKEN>
				<TOKEN id="token-39-17" start_char="5869" end_char="5875">Georgia</TOKEN>
				<TOKEN id="token-39-18" start_char="5877" end_char="5878">in</TOKEN>
				<TOKEN id="token-39-19" start_char="5880" end_char="5883">2015</TOKEN>
				<TOKEN id="token-39-20" start_char="5884" end_char="5884">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-40" start_char="5886" end_char="6005">
				<ORIGINAL_TEXT>The Lugar Lab is a diagnostic facility for various infectious diseases, including hepatitis C, not a treatment facility.</ORIGINAL_TEXT>
				<TOKEN id="token-40-0" start_char="5886" end_char="5888">The</TOKEN>
				<TOKEN id="token-40-1" start_char="5890" end_char="5894">Lugar</TOKEN>
				<TOKEN id="token-40-2" start_char="5896" end_char="5898">Lab</TOKEN>
				<TOKEN id="token-40-3" start_char="5900" end_char="5901">is</TOKEN>
				<TOKEN id="token-40-4" start_char="5903" end_char="5903">a</TOKEN>
				<TOKEN id="token-40-5" start_char="5905" end_char="5914">diagnostic</TOKEN>
				<TOKEN id="token-40-6" start_char="5916" end_char="5923">facility</TOKEN>
				<TOKEN id="token-40-7" start_char="5925" end_char="5927">for</TOKEN>
				<TOKEN id="token-40-8" start_char="5929" end_char="5935">various</TOKEN>
				<TOKEN id="token-40-9" start_char="5937" end_char="5946">infectious</TOKEN>
				<TOKEN id="token-40-10" start_char="5948" end_char="5955">diseases</TOKEN>
				<TOKEN id="token-40-11" start_char="5956" end_char="5956">,</TOKEN>
				<TOKEN id="token-40-12" start_char="5958" end_char="5966">including</TOKEN>
				<TOKEN id="token-40-13" start_char="5968" end_char="5976">hepatitis</TOKEN>
				<TOKEN id="token-40-14" start_char="5978" end_char="5978">C</TOKEN>
				<TOKEN id="token-40-15" start_char="5979" end_char="5979">,</TOKEN>
				<TOKEN id="token-40-16" start_char="5981" end_char="5983">not</TOKEN>
				<TOKEN id="token-40-17" start_char="5985" end_char="5985">a</TOKEN>
				<TOKEN id="token-40-18" start_char="5987" end_char="5995">treatment</TOKEN>
				<TOKEN id="token-40-19" start_char="5997" end_char="6004">facility</TOKEN>
				<TOKEN id="token-40-20" start_char="6005" end_char="6005">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-41" start_char="6007" end_char="6149">
				<ORIGINAL_TEXT>Some patients involved in the hepatitis C elimination program died due to severity of their health condition, not as a result of the treatment.</ORIGINAL_TEXT>
				<TOKEN id="token-41-0" start_char="6007" end_char="6010">Some</TOKEN>
				<TOKEN id="token-41-1" start_char="6012" end_char="6019">patients</TOKEN>
				<TOKEN id="token-41-2" start_char="6021" end_char="6028">involved</TOKEN>
				<TOKEN id="token-41-3" start_char="6030" end_char="6031">in</TOKEN>
				<TOKEN id="token-41-4" start_char="6033" end_char="6035">the</TOKEN>
				<TOKEN id="token-41-5" start_char="6037" end_char="6045">hepatitis</TOKEN>
				<TOKEN id="token-41-6" start_char="6047" end_char="6047">C</TOKEN>
				<TOKEN id="token-41-7" start_char="6049" end_char="6059">elimination</TOKEN>
				<TOKEN id="token-41-8" start_char="6061" end_char="6067">program</TOKEN>
				<TOKEN id="token-41-9" start_char="6069" end_char="6072">died</TOKEN>
				<TOKEN id="token-41-10" start_char="6074" end_char="6076">due</TOKEN>
				<TOKEN id="token-41-11" start_char="6078" end_char="6079">to</TOKEN>
				<TOKEN id="token-41-12" start_char="6081" end_char="6088">severity</TOKEN>
				<TOKEN id="token-41-13" start_char="6090" end_char="6091">of</TOKEN>
				<TOKEN id="token-41-14" start_char="6093" end_char="6097">their</TOKEN>
				<TOKEN id="token-41-15" start_char="6099" end_char="6104">health</TOKEN>
				<TOKEN id="token-41-16" start_char="6106" end_char="6114">condition</TOKEN>
				<TOKEN id="token-41-17" start_char="6115" end_char="6115">,</TOKEN>
				<TOKEN id="token-41-18" start_char="6117" end_char="6119">not</TOKEN>
				<TOKEN id="token-41-19" start_char="6121" end_char="6122">as</TOKEN>
				<TOKEN id="token-41-20" start_char="6124" end_char="6124">a</TOKEN>
				<TOKEN id="token-41-21" start_char="6126" end_char="6131">result</TOKEN>
				<TOKEN id="token-41-22" start_char="6133" end_char="6134">of</TOKEN>
				<TOKEN id="token-41-23" start_char="6136" end_char="6138">the</TOKEN>
				<TOKEN id="token-41-24" start_char="6140" end_char="6148">treatment</TOKEN>
				<TOKEN id="token-41-25" start_char="6149" end_char="6149">.</TOKEN>
			</SEG>
			<SEG id="covid19scenario-56-42" start_char="6151" end_char="6208">
				<ORIGINAL_TEXT>This conspiracy theory was debunked by many media outlets.</ORIGINAL_TEXT>
				<TOKEN id="token-42-0" start_char="6151" end_char="6154">This</TOKEN>
				<TOKEN id="token-42-1" start_char="6156" end_char="6165">conspiracy</TOKEN>
				<TOKEN id="token-42-2" start_char="6167" end_char="6172">theory</TOKEN>
				<TOKEN id="token-42-3" start_char="6174" end_char="6176">was</TOKEN>
				<TOKEN id="token-42-4" start_char="6178" end_char="6185">debunked</TOKEN>
				<TOKEN id="token-42-5" start_char="6187" end_char="6188">by</TOKEN>
				<TOKEN id="token-42-6" start_char="6190" end_char="6193">many</TOKEN>
				<TOKEN id="token-42-7" start_char="6195" end_char="6199">media</TOKEN>
				<TOKEN id="token-42-8" start_char="6201" end_char="6207">outlets</TOKEN>
				<TOKEN id="token-42-9" start_char="6208" end_char="6208">.</TOKEN>
			</SEG>
		</TEXT>
	</DOC>
</LCTL_TEXT>
